hg_142813.1

Basic information about the TSS

---

TSS ID: hg_142813.1 Species: human Chr: chr14		Start: 34714693 End: 34714704 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000298159.10 uc001wsh.4 BC022876 BC022364 Distance: 4 GeneID: 1073 HGNC/MGI_ID: HGNC:1875 UniProt_ID: Q549N0 Q9Y281

Gene_name: cofilin 2 Gene_symbol: CFL2 Gene_synonyms: NEM7 Gene_source: HGNC:1875

TATA-Box annotation

---

Distance to TSS:	124
Nearest PromoterID:	NR_028131
Entrez ID:	1073
Nearest Unigene:	Hs.180141
Nearest Refseq:	NM_021914
Nearest Ensembl:	ENSG00000165410
Gene Name:	cofilin 2
Gene Alias:	NEM7
Gene Description:	cofilin 2
Gene Type:	protein-coding
CpG%:	0.135
GC%:	0.810945
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CFL2 p2@CFL2 p3@CFL2 p4@CFL2 p6@CFL2 p7@CFL2 p8@CFL2 p9@CFL2 p10@CFL2
Sample		p1@CFL2	p2@CFL2	p3@CFL2	p4@CFL2	p6@CFL2	p7@CFL2	p8@CFL2	p9@CFL2	p10@CFL2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	34.09	28.25	2.92	2.92	0.39	1.17	2.14	2.73	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	31.36	25.90	2.23	2.23	0.20	0.40	1.62	2.23	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	43.02	24.31	2.70	2.51	0.58	0.39	0.96	1.35	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	36.38	22.04	2.70	1.46	0.21	0.83	0.83	2.49	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	34.19	26.32	2.25	2.02	0.45	0.67	1.35	1.35	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	36.24	27.71	4.46	0.78	0.19	1.16	0.78	3.68	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	70.16	43.36	4.14	3.70	0.44	1.09	1.74	3.05	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	41.66	30.28	3.15	4.12	0.48	1.70	0.24	3.63	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	44.67	23.30	4.70	2.99	0.64	1.92	0.85	4.49	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	51.59	30.14	4.06	4.06	0.00	1.74	1.74	7.54	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	43.25	21.83	2.43	3.23	0.00	4.45	1.21	9.30	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	53.26	36.18	0.81	3.25	0.41	3.25	2.85	4.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	45.13	5.80	3.22	3.22	0.32	0.97	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	53.67	5.11	3.46	3.46	0.15	0.90	0.75	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	36.01	6.59	2.85	2.63	0.22	0.66	0.22	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	47.78	4.53	2.77	3.77	1.01	0.25	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	48.05	6.77	3.49	3.06	0.66	1.09	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	43.87	5.06	3.80	1.69	0.42	1.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	42.12	5.86	2.13	2.13	1.60	1.07	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	34.60	4.36	2.11	2.41	0.45	0.45	0.45	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	41.97	4.28	2.81	3.74	0.53	0.94	1.20	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	41.77	4.83	2.07	3.97	1.21	0.86	0.52	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	51.19	7.37	2.71	5.04	0.39	0.78	0.39	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.41	5.82	3.64	2.18	0.73	0.49	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	40.25	4.90	1.81	2.06	0.77	0.77	0.26	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	39.56	3.48	5.38	3.48	0.32	1.58	0.95	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	48.35	5.49	4.40	2.20	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	39.13	4.95	3.77	2.12	0.71	0.71	0.94	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	36.02	3.23	2.58	1.45	0.48	0.48	0.48	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	44.16	4.16	3.44	1.99	0.90	0.54	0.72	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	41.03	5.02	1.67	2.30	0.63	0.84	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	33.80	5.86	1.17	1.95	0.39	0.59	0.59	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	38.62	6.75	2.74	1.48	0.63	0.63	1.27	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	61.85	7.92	3.13	5.11	0.82	0.16	1.15	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	38.89	5.61	2.24	2.43	0.75	0.56	1.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	36.79	4.41	1.92	4.02	0.77	0.00	0.77	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	29.02	5.11	2.66	2.66	1.23	1.02	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.06	4.43	1.41	0.81	0.00	0.40	0.81	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.38	3.78	2.16	1.89	0.81	0.27	0.27	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	37.21	4.56	0.96	3.36	0.72	1.92	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.11	5.41	3.76	1.88	0.47	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	45.38	6.73	2.93	2.49	0.59	1.02	0.29	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	29.53	2.53	1.69	1.90	0.63	0.63	1.48	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.00	6.64	2.27	2.45	0.70	0.17	1.40	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	30.72	4.02	2.61	0.60	0.20	0.20	1.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.62	3.02	1.40	2.33	0.00	0.70	2.56	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.43	5.52	1.68	0.48	0.00	0.48	1.44	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	25.04	4.77	1.79	2.09	0.89	0.00	2.09	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	25.13	2.87	2.15	0.48	1.20	0.48	1.20	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	24.67	6.27	1.62	1.62	0.61	0.20	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.67	3.69	1.84	2.05	0.61	0.41	1.64	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	32.02	2.00	2.67	1.78	0.44	0.67	1.56	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	475.73	55.97	13.99	41.98	13.99	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	19.87	2.13	1.06	0.71	0.00	1.06	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	20.88	1.33	1.33	0.66	0.33	0.33	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	166.11	10.07	4.19	9.23	0.84	0.84	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	54.19	4.59	2.76	5.51	0.92	0.46	0.92	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.42	3.24	1.94	2.27	0.97	0.65	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	2.25	2.25	0.32	0.32	0.64	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	43.38	5.66	3.14	1.89	0.31	1.26	1.57	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	18.33	4.23	0.71	0.71	0.00	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.19	2.24	1.68	0.56	0.00	0.56	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	82.80	4.78	3.18	10.35	0.00	0.00	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	30.92	5.10	2.72	2.72	0.68	0.00	0.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.87	2.60	2.60	2.92	0.97	0.00	1.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.88	3.19	1.77	1.42	0.00	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	323.28	64.66	32.33	48.49	0.00	0.00	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	489.64	31.59	23.69	0.00	31.59	7.90	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	22.43	2.93	1.95	0.98	0.00	0.00	1.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	22.31	3.47	1.98	3.47	0.00	0.50	3.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	23.92	3.75	1.41	3.75	0.00	0.47	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	50.34	4.31	1.66	3.64	0.33	0.33	3.31	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	39.29	2.78	0.62	3.40	0.31	0.00	0.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	42.19	4.89	1.22	1.83	0.31	0.31	2.14	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	83.47	13.78	9.82	6.97	5.07	2.22	0.63	0.95	0.16
Adipocyte - breast, donor2	11327-117E4	58.56	14.44	6.58	4.17	3.05	1.60	0.64	0.96	0.00
Adipocyte - omental, donor1	11473-119C6	115.65	31.17	10.18	9.41	3.05	1.78	1.02	1.40	1.02
Adipocyte - omental, donor2	11474-119C7	61.29	10.46	2.24	8.97	1.49	0.75	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	48.23	10.72	5.02	3.68	1.34	1.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	64.44	21.69	1.28	7.66	1.91	2.55	0.64	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	9.90	5.50	1.10	0.00	0.00	1.10	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	22.58	4.06	1.81	0.90	1.81	0.00	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	15.99	7.30	5.04	0.70	1.56	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	39.51	10.17	5.67	1.76	1.17	0.20	1.37	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	12.87	3.35	1.54	0.51	0.00	0.00	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	24.53	7.53	1.67	1.95	0.56	0.56	0.56	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	6.47	4.11	0.59	0.59	0.00	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	32.58	12.23	6.11	1.93	3.22	0.40	0.40	0.00	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	22.92	6.46	2.90	1.29	0.32	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	14.93	3.73	2.13	1.60	1.07	0.00	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	25.60	6.12	3.34	0.56	0.56	0.56	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.13	10.81	2.91	1.25	2.91	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	14.07	3.52	3.27	0.75	1.00	0.00	0.50	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	20.62	4.25	4.25	0.33	0.98	0.33	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	14.01	9.44	3.65	0.61	1.22	0.30	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	26.96	12.82	3.54	1.10	2.65	0.00	1.10	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	2.51	10.04	0.00	0.36	1.79	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	5.99	1.20	0.00	2.40	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	28.78	19.25	5.76	1.08	3.06	0.18	0.72	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	10.04	8.37	0.00	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	15.61	7.60	2.67	0.21	3.08	0.21	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	143.83	23.91	8.35	6.52	2.06	1.03	0.57	0.57	0.46
Anulus Pulposus Cell, donor2	11463-119B5	75.19	18.37	6.12	1.71	2.94	0.00	1.22	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	70.09	21.57	3.15	6.74	1.35	2.70	0.90	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	77.28	26.92	4.78	2.17	1.74	1.74	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	74.91	23.54	12.84	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	69.65	23.61	3.89	5.08	1.49	1.79	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	94.85	24.03	7.59	8.85	3.79	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	58.09	18.48	3.96	1.98	1.32	0.00	0.00	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	63.35	17.22	6.17	2.60	0.97	1.95	0.32	1.62	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	71.85	25.24	5.34	2.91	1.94	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	78.99	25.54	4.75	5.94	1.19	1.19	0.00	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	70.05	25.99	4.14	5.27	2.64	1.51	0.00	1.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	63.86	17.42	5.08	0.73	2.90	0.73	0.73	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	77.73	18.81	7.52	0.00	1.25	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	124.21	35.25	8.24	7.74	2.31	1.65	0.82	2.31	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	65.51	19.11	4.09	2.73	2.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	72.68	20.66	4.98	3.47	1.36	0.75	0.45	1.21	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	72.33	22.50	5.36	3.21	2.68	2.14	1.07	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	64.62	25.32	5.10	2.46	1.32	1.51	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	82.06	24.59	5.35	4.28	1.60	0.53	0.53	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	44.87	20.48	5.85	3.90	0.00	0.98	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	82.10	22.06	6.97	2.16	2.16	1.00	0.66	0.33	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	79.25	20.41	3.60	3.60	0.00	2.40	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	88.50	28.32	0.00	0.00	0.00	0.00	0.00	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	66.38	24.53	5.66	3.95	2.23	0.86	0.51	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	12.58	4.19	4.19	0.00	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	68.93	25.73	3.40	3.88	2.43	0.97	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	81.20	26.94	4.55	3.04	3.42	2.28	1.14	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	65.41	14.54	7.27	3.63	0.00	1.21	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	67.83	23.94	5.70	3.99	0.57	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	66.06	19.03	2.78	5.34	1.50	1.50	0.43	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	58.07	21.16	6.71	1.81	0.77	1.29	0.77	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	57.71	21.58	5.63	2.82	0.47	2.82	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	65.60	20.26	6.43	1.93	1.93	0.64	0.64	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	52.08	19.98	5.71	2.14	1.43	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	57.33	23.98	4.09	1.17	2.34	1.75	0.00	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	78.88	20.77	3.91	2.71	2.71	0.60	0.00	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	61.78	15.44	5.94	1.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	82.90	24.41	4.07	6.10	1.02	1.02	1.02	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	65.20	21.65	5.09	3.06	2.29	0.25	0.51	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	67.98	20.97	2.54	3.81	1.91	1.27	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	64.30	22.44	3.02	2.59	1.29	0.86	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	64.35	20.53	4.23	4.02	1.69	1.06	0.42	0.85	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	65.25	17.69	6.67	4.93	1.45	0.87	0.58	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	58.57	24.56	6.61	0.00	0.94	0.00	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	67.30	18.14	4.07	2.54	1.53	1.36	0.51	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	53.28	20.85	4.63	0.00	0.00	0.00	0.00	2.32	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	46.48	35.91	4.23	2.11	4.23	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	57.89	21.44	6.43	4.93	1.72	1.07	0.64	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	57.16	18.65	6.02	3.01	0.00	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	56.13	19.68	0.73	2.92	2.19	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	82.99	23.45	4.60	5.06	0.69	1.61	0.92	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	91.81	22.95	2.55	5.10	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	100.42	29.24	5.85	8.14	1.02	1.78	0.76	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	74.32	26.84	4.34	4.75	3.10	2.27	1.03	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	63.34	22.03	5.20	1.53	1.22	2.14	0.61	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	78.87	24.38	4.30	6.21	2.39	0.96	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	65.19	18.63	3.99	4.43	1.55	0.89	0.22	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	61.03	13.73	1.53	0.00	0.00	3.05	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	61.48	16.62	2.77	1.11	0.55	2.22	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	64.08	19.86	5.03	5.56	2.12	1.06	0.79	1.32	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	53.79	24.35	4.00	2.18	0.36	2.54	0.73	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	57.48	37.21	4.54	4.18	2.95	1.11	0.61	0.74	0.00
Astrocyte - cerebellum, donor2	11580-120F5	20.37	23.28	2.91	1.03	2.05	0.34	0.86	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.18	9.44	4.40	1.05	0.63	0.42	0.63	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	81.92	12.55	5.93	4.18	3.14	0.00	1.05	1.74	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	59.05	15.53	7.60	3.72	3.07	0.49	0.65	0.65	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	54.59	12.08	5.37	3.13	1.34	1.94	1.19	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	4.70	2.52	1.26	0.11	0.46	0.11	0.92	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	4.01	2.38	1.88	0.25	0.75	0.00	0.88	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	3.98	2.16	0.46	0.11	0.23	0.00	0.68	0.00	0.00
Basophils, donor1	12241-129G9	3.14	1.31	0.52	0.26	0.52	0.00	3.92	0.52	0.00
Basophils, donor2	12242-129H1	24.17	11.91	4.33	1.08	0.36	0.36	2.89	0.00	0.00
Basophils, donor3	12243-129H2	4.85	3.53	0.88	0.73	0.44	0.00	2.65	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.08	2.16	0.86	0.00	0.65	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.46	0.91	0.46	0.00	0.91	0.00	1.37	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	1.26	1.26	1.26	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	3.12	3.95	0.83	0.00	0.62	0.00	0.83	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.68	3.91	1.38	0.23	1.15	0.23	0.46	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	4.50	0.90	0.72	0.18	0.54	0.00	0.54	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	38.13	8.76	1.75	3.40	0.52	1.55	0.10	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	33.54	8.15	2.10	1.86	1.86	0.47	0.70	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.87	6.40	3.52	0.00	1.92	0.00	0.96	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	31.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.94	1.69	0.56	0.56	0.56	0.56	1.69	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	1.48	1.67	1.48	0.74	0.37	0.37	3.34	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	3.51	1.54	1.32	0.22	0.22	0.44	5.93	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	8.49	5.38	1.98	1.13	0.85	0.57	0.28	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	7.96	4.17	3.03	0.76	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	10.85	10.85	5.59	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	2.17	0.87	1.30	0.00	0.29	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.30	1.21	0.60	0.00	0.30	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.32	3.08	0.47	0.24	0.71	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.33	0.50	0.00	0.00	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.49	0.99	0.50	0.00	0.50	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1.57	0.39	0.39	0.00	0.20	0.00	0.98	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.53	0.71	0.00	0.18	0.18	0.00	0.89	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.96	1.74	0.22	0.00	0.44	0.00	0.87	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	1.11	1.11	0.00	1.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.59	0.89	0.30	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.00	0.60	0.20	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.29	1.67	1.25	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.00	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.45	0.00	0.23	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.44	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.88	0.81	0.54	0.00	0.27	0.00	0.81	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.05	1.05	0.87	0.00	0.17	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	2.95	3.37	0.84	0.00	0.00	0.42	0.42	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	0.00	0.00	0.00	0.35	0.00	0.70	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.22	0.70	0.00	0.35	0.35	0.35	0.52	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.37	0.74	0.37	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	1.72	3.02	0.22	0.22	0.43	0.22	0.22	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	2.05	2.46	0.00	0.41	0.41	0.00	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.70	0.23	0.00	0.23	0.00	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.62	0.23	0.00	0.00	0.00	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	3.49	1.74	0.44	0.00	1.09	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	5.54	1.39	1.85	0.00	0.69	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	4.55	3.03	1.73	0.00	0.65	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	5.45	3.58	1.09	0.31	1.09	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	4.89	2.10	1.92	0.17	0.52	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	10.70	6.47	2.45	0.45	0.67	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	1.53	1.28	0.26	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.95	0.88	1.98	0.00	0.44	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	7.37	3.58	1.26	0.21	0.84	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	12.19	10.16	4.06	0.00	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	13.56	2.71	1.36	0.68	0.68	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	15.53	10.36	7.25	3.11	1.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	11.19	4.80	4.26	0.53	1.07	0.00	3.20	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	18.76	8.58	7.50	1.07	1.07	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	20.36	14.04	5.62	2.11	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	11.77	20.39	3.14	0.00	2.35	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	18.46	15.82	1.32	1.32	2.64	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	51.78	36.16	4.93	3.29	0.00	0.82	32.05	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	26.84	5.80	5.08	0.73	0.73	1.45	21.76	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	45.94	23.73	4.54	1.01	1.51	0.50	30.79	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	15.76	2.42	2.02	0.40	0.40	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	12.78	2.00	2.00	0.80	0.40	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	12.05	4.02	0.00	0.00	0.00	0.00	6.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	8.43	3.37	0.56	0.00	0.56	0.00	21.91	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	7.52	1.50	1.50	0.75	0.75	0.38	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	9.92	1.80	2.71	0.45	0.68	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	13.57	5.71	2.50	2.50	2.14	0.36	49.63	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	8.57	4.90	1.84	1.84	1.22	1.22	44.09	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	9.45	2.74	2.13	1.22	0.61	0.30	14.64	0.61	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	4.59	3.06	1.28	0.00	0.77	0.00	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.61	4.04	2.25	0.00	1.12	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	6.61	8.62	4.31	0.57	1.44	0.00	0.86	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	24.18	5.69	3.79	0.95	0.00	0.00	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	19.67	5.62	2.81	0.00	1.40	0.00	2.81	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	3.30	0.00	0.00	3.30	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	9.39	4.05	1.88	0.29	1.30	0.14	1.01	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	5.08	3.90	2.20	0.00	1.69	0.00	0.68	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	4.35	5.32	2.74	0.32	1.45	0.00	1.61	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.90	4.93	1.34	0.45	1.34	0.00	1.79	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	13.28	4.89	1.75	1.05	0.70	0.00	4.19	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	25.52	9.24	2.20	0.00	0.44	0.00	1.32	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	5.48	2.95	1.69	0.42	1.26	0.00	0.84	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	2.49	1.66	1.04	0.00	0.42	0.00	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	5.35	4.68	2.67	0.67	0.67	0.00	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	16.32	4.62	1.36	1.63	1.36	0.00	2.45	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	21.44	8.58	2.14	0.00	1.07	0.54	2.14	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	17.93	10.76	0.00	1.79	0.00	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	7.05	3.34	1.85	0.00	1.48	0.00	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	4.33	2.38	2.38	0.22	1.30	0.00	0.87	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	7.78	5.04	2.94	0.84	1.89	0.21	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.18	3.03	2.53	0.00	2.02	0.51	3.03	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	10.83	4.33	2.17	0.00	1.73	0.43	2.17	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	22.23	11.77	3.92	0.44	0.87	0.00	4.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	15.84	8.41	5.94	0.99	1.48	0.49	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	10.16	8.31	1.85	2.77	0.92	0.00	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	12.56	12.56	6.98	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	11.35	6.09	0.83	1.11	0.55	0.28	0.55	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	17.91	6.13	0.49	1.47	2.45	0.00	0.98	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	20.02	15.40	0.00	0.00	0.00	1.54	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	12.89	12.53	5.01	1.79	0.36	0.00	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	13.85	2.77	0.00	1.38	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	14.08	6.22	2.62	1.31	0.98	0.65	3.93	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	15.39	4.88	2.25	1.50	0.75	1.13	19.52	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	17.42	6.56	3.28	1.51	0.50	0.76	32.57	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.44	0.92	0.46	0.00	0.00	0.00	0.69	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	2.64	0.72	0.48	0.48	0.24	0.24	0.48	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.10	0.82	0.82	0.00	0.00	0.00	0.27	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.60	2.10	0.90	0.30	0.00	0.00	1.20	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.12	1.20	0.72	0.00	0.24	0.24	0.48	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.78	0.68	0.23	0.23	0.23	0.00	1.14	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.13	0.87	0.43	0.00	1.09	0.00	0.65	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.90	1.05	0.53	0.26	0.00	0.00	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.69	1.64	0.23	0.23	0.94	0.00	0.94	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	4.83	0.91	1.21	0.30	0.30	0.30	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.36	2.03	0.00	0.29	0.00	0.29	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.93	1.60	0.27	0.53	0.00	0.00	1.07	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	2.19	0.44	0.00	0.88	0.88	1.31	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	4.10	0.91	0.00	1.82	0.00	0.46	1.82	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	0.00	0.00	0.75	0.00	0.75	2.24	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	3.60	1.08	0.36	0.00	0.00	0.00	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.30	1.15	0.86	0.58	0.58	0.00	0.86	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.59	1.18	0.00	0.47	0.47	0.00	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.80	1.90	0.63	1.27	0.32	0.00	1.27	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.92	0.62	0.00	0.00	0.31	0.00	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.85	1.28	0.64	0.64	0.00	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.44	0.00	0.38	0.38	0.38	0.38	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.15	1.58	1.58	0.39	0.39	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	3.21	4.01	0.00	1.61	1.61	3.21	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	4.90	4.20	1.40	2.80	1.40	0.00	3.50	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	16.03	1.00	1.00	1.00	3.01	0.00	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	51.18	5.48	5.48	1.83	1.83	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	34.09	10.87	4.94	0.49	3.46	0.00	2.47	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	47.46	9.79	5.79	2.42	2.42	0.74	0.63	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	104.00	11.79	2.77	5.20	4.16	1.73	1.39	1.73	0.35
Chondrocyte - de diff, donor2	11338-117F6	62.90	11.02	4.62	4.62	3.20	0.71	2.49	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	70.66	14.79	9.33	3.98	2.05	1.37	0.46	0.57	0.23
Chondrocyte - re diff, donor2	11339-117F7	34.91	10.74	3.58	2.69	2.69	0.90	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	18.20	4.45	3.64	0.40	0.40	0.81	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	97.31	20.43	6.54	5.28	2.75	1.03	2.07	0.57	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	54.51	16.46	6.63	4.49	1.28	1.07	2.78	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	53.10	14.07	6.73	2.92	1.59	0.88	2.74	0.18	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	61.16	15.96	6.51	7.43	2.11	2.29	1.93	1.65	0.28
Corneal Epithelial Cells, donor1	11526-119I5	1.98	3.29	1.76	0.00	0.22	0.00	0.22	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	2.28	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.30	2.05	1.28	0.26	1.02	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	2.81	1.98	1.16	0.33	0.50	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.10	2.84	2.21	0.00	0.63	0.00	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	3.45	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	1.30	0.86	0.65	0.11	0.22	0.00	0.11	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.01	8.20	2.73	0.68	1.37	0.34	1.37	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	12.40	8.49	2.61	0.00	1.31	0.00	0.00	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	19.84	10.16	3.87	0.97	1.45	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	38.36	13.84	5.67	1.83	2.84	0.17	0.33	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	22.30	9.98	2.93	0.59	0.59	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	26.30	10.18	2.83	1.41	0.85	0.28	1.13	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	29.49	7.86	4.33	1.18	3.15	0.39	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	16.00	7.56	2.91	0.29	0.58	0.29	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	21.18	7.29	5.41	0.47	1.65	0.24	0.47	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	29.63	11.75	7.71	1.40	1.75	0.18	0.18	1.05	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.66	9.53	8.64	1.77	2.66	0.66	0.44	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.64	10.95	5.78	3.35	1.83	0.91	0.61	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.80	14.10	5.36	1.97	1.97	0.56	0.85	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	48.73	13.97	2.38	1.78	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	43.74	14.58	4.17	2.60	1.56	1.56	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	14.60	6.24	4.68	0.14	0.71	0.00	0.28	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	91.23	34.01	3.60	2.80	4.00	0.80	0.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	13.10	2.62	1.57	1.05	0.00	1.05	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	112.07	24.60	9.57	6.34	5.34	1.24	0.62	0.75	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	43.45	9.99	4.35	1.30	1.74	0.43	0.87	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.74	14.17	7.08	1.71	1.34	0.61	0.61	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	13.65	2.28	5.69	1.14	2.28	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	15.37	6.99	2.10	0.70	1.40	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	26.53	7.85	3.61	1.73	1.73	0.63	0.79	0.63	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	30.49	0.00	0.00	0.00	45.74	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00	1.65	0.00	0.00	0.00	34.66	1.65	0.00
Eosinophils, donor3	12246-129H5	14.27	10.70	3.57	0.00	0.00	0.00	39.24	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.71	2.20	1.22	0.24	0.98	0.00	1.22	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	61.58	13.96	7.39	4.11	3.28	0.82	0.41	0.82	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	32.52	7.66	3.39	2.85	0.77	1.53	0.77	0.44	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	49.29	9.97	3.90	3.36	1.41	0.54	0.98	0.33	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	86.11	17.10	8.49	4.37	2.55	2.18	1.94	0.73	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	55.82	14.60	6.28	4.23	2.05	1.36	0.68	0.96	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	47.78	14.24	6.12	2.21	2.74	0.95	1.90	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	23.19	6.59	1.05	0.26	0.79	0.00	0.26	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	49.17	12.62	5.32	3.32	1.66	0.66	1.99	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	49.45	15.42	4.54	2.72	0.91	0.91	1.81	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	34.11	19.71	3.03	1.52	1.52	0.00	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	22.40	8.36	4.42	1.26	1.10	0.00	0.47	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	66.99	14.85	7.27	3.33	2.73	0.61	0.91	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	54.82	13.83	4.31	2.16	2.41	0.51	1.02	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	47.75	13.19	4.55	3.03	2.27	0.91	1.21	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.80	12.46	2.14	0.94	3.35	0.00	1.07	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.57	7.77	3.45	1.73	1.73	0.00	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	5.86	1.46	2.93	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	24.91	25.60	6.23	1.38	2.77	0.69	0.69	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	115.67	25.95	11.87	3.05	3.39	0.34	1.19	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	58.93	20.90	3.76	3.29	1.41	0.94	0.70	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	50.47	19.81	4.25	0.94	2.36	0.94	1.42	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	79.54	17.41	9.31	3.26	2.54	0.85	1.09	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	107.28	20.57	3.62	8.25	3.05	1.92	0.34	0.79	0.23
Fibroblast - Dermal, donor5	11454-119A5	113.92	23.38	2.97	6.63	2.62	0.87	1.22	0.52	0.17
Fibroblast - Dermal, donor6	11458-119A9	125.39	20.95	4.39	8.93	4.39	1.46	0.97	0.97	0.16
Fibroblast - Gingival, donor1	11237-116D4	128.48	23.95	10.20	7.50	4.16	2.29	0.42	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	122.35	24.89	11.00	6.81	3.41	3.41	1.83	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	94.49	17.26	7.12	5.80	2.77	1.58	0.53	0.92	0.00
Fibroblast - Gingival, donor3	11394-118C8	88.18	16.44	13.54	4.45	2.22	1.45	0.58	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	137.13	13.51	4.16	4.16	3.12	4.16	0.00	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	79.12	13.74	7.58	6.52	2.11	4.05	0.53	0.88	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	137.81	28.22	8.26	8.57	3.74	4.05	1.40	1.87	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	162.95	26.64	5.14	13.12	2.98	6.09	0.54	2.43	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	111.51	20.47	4.94	11.65	1.41	5.29	3.88	2.82	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	165.40	29.83	8.04	11.41	2.49	7.75	1.46	3.36	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	189.80	32.32	7.64	15.54	2.45	6.54	1.77	2.86	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	147.76	28.96	6.47	13.82	2.41	5.48	1.65	2.63	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	121.06	15.70	5.43	12.33	1.61	6.46	1.17	3.52	0.44
Fibroblast - Lung, donor1	11270-116H1	29.91	14.95	6.80	0.00	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	74.61	11.94	4.48	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	39.46	24.06	5.70	3.17	1.90	0.63	0.21	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	68.31	52.48	6.66	3.33	5.00	1.67	1.67	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	44.76	12.59	6.99	0.00	2.80	1.40	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.47	11.20	4.48	0.56	2.24	0.00	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	88.10	41.41	10.56	5.28	4.47	0.81	4.47	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	31.95	15.98	7.99	0.00	0.00	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	23.83	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	134.04	26.38	8.15	9.12	2.72	2.52	0.78	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	89.19	16.99	7.58	6.07	2.58	0.30	0.91	1.06	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	177.47	32.43	12.24	11.32	4.59	3.67	0.31	2.14	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	140.06	26.33	3.05	7.25	2.29	5.72	1.53	1.14	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	165.77	35.91	7.56	14.58	2.43	5.67	1.35	2.43	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	74.22	16.12	8.47	5.22	2.20	4.18	1.62	1.16	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	62.45	16.25	7.96	4.31	2.10	0.66	0.88	0.55	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	43.08	50.59	9.75	2.03	6.10	0.81	1.83	0.41	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	21.38	15.37	4.01	2.67	0.67	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	58.91	10.67	3.56	1.19	1.19	0.79	0.79	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	80.97	18.06	5.75	4.96	3.18	1.98	0.99	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	163.23	21.85	6.75	18.29	1.95	7.99	1.60	1.42	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	144.66	20.89	8.28	12.61	1.58	3.35	2.96	0.39	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	52.65	14.14	3.01	1.50	2.11	2.41	0.30	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	194.20	34.00	5.94	15.01	5.51	3.24	2.27	2.59	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	79.21	15.44	1.27	4.81	3.29	0.76	0.51	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	153.58	23.63	7.06	12.47	4.10	3.45	0.66	1.31	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	88.22	24.26	4.61	4.21	2.41	0.60	0.40	0.40	1.00
Fibroblast - skin normal, donor2	11561-120D4	169.08	24.91	4.22	10.85	5.73	3.42	1.71	1.51	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	95.20	29.01	4.23	5.74	4.84	2.12	1.81	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	202.89	30.65	14.25	15.91	4.31	3.98	2.65	2.07	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	88.21	14.87	4.79	3.59	1.54	0.68	1.88	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	69.30	15.76	7.23	4.60	1.97	2.96	0.66	0.99	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	257.68	49.53	6.92	19.17	5.54	4.47	1.17	2.98	0.96
Fibroblast - skin walker warburg, donor1	11554-120C6	146.08	28.34	7.25	11.30	3.54	3.54	0.84	1.69	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	250.60	29.80	10.04	22.58	3.76	5.49	1.25	2.35	3.76
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	3811.48	199.44	0.00	155.12	22.16	22.16	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	0.87	0.00	0.87	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	24.27	12.66	3.81	1.04	1.04	0.00	0.69	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	14.05	5.47	3.64	1.04	1.56	0.00	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.80	5.11	2.30	1.53	2.30	0.26	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	12.25	2.30	0.00	0.77	0.00	0.77	0.77	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.04	3.19	2.55	0.00	0.00	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	25.10	7.13	2.00	0.57	0.57	0.57	0.29	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.64	3.58	1.93	1.38	0.83	0.00	0.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	22.15	5.02	3.42	0.91	0.68	0.23	0.00	0.23	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	14.86	5.35	1.19	0.79	0.99	0.20	0.59	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.43	3.97	1.32	1.59	0.26	1.32	0.26	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	19.24	6.85	3.26	1.63	1.63	0.33	0.98	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.94	5.31	0.88	0.44	0.88	0.44	0.44	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	13.85	2.97	1.27	0.57	0.28	0.14	0.28	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.78	4.56	1.11	0.25	0.74	0.12	0.37	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.40	1.88	1.61	0.54	0.54	0.00	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	22.80	5.33	0.87	0.50	0.62	0.00	0.62	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.98	3.46	0.42	0.55	0.83	0.00	0.69	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	11.59	3.05	1.22	0.61	0.61	0.20	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.83	6.39	1.60	0.46	0.46	0.23	0.23	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	15.94	3.49	0.62	0.75	0.37	0.37	0.37	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	9.18	4.15	0.87	0.22	0.66	0.00	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.34	5.61	1.48	0.00	0.59	0.30	0.30	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.03	6.20	1.75	1.43	1.11	0.00	0.32	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	15.86	6.03	0.89	0.22	0.45	0.22	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.80	5.85	2.42	1.01	0.81	0.20	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	29.35	8.31	3.56	2.37	0.68	0.51	0.51	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	37.60	8.78	3.46	1.24	1.15	0.27	0.53	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.94	13.22	4.68	1.77	1.56	0.10	0.42	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	72.58	9.91	3.76	1.54	1.37	0.34	0.68	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	30.87	7.75	3.10	0.89	0.77	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.44	11.07	3.49	1.41	1.66	0.33	0.33	0.08	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.18	8.17	2.65	1.63	1.23	0.20	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	36.72	9.49	2.89	2.48	0.62	0.83	0.41	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.16	6.80	2.19	1.84	0.92	0.12	0.69	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	27.18	6.17	2.84	1.17	0.67	0.50	0.17	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	29.10	5.07	1.98	0.66	0.44	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.04	5.29	1.60	2.34	0.74	0.49	0.37	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.12	6.65	2.59	0.97	0.97	0.49	0.32	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	30.47	8.66	1.60	0.32	0.96	0.32	0.96	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	28.81	7.30	0.38	0.66	0.38	0.28	0.09	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	27.21	6.49	3.32	2.06	1.42	0.16	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	33.45	3.65	1.52	0.91	0.91	0.30	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	25.72	6.69	1.78	1.25	0.94	0.31	0.21	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.01	7.46	3.29	0.66	0.44	0.44	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	29.18	7.29	1.12	0.56	1.96	0.00	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	23.33	5.65	3.24	0.93	0.46	0.09	0.09	0.00	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	36.37	8.29	4.01	2.41	1.87	1.07	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	26.47	6.89	4.13	1.07	0.77	0.31	0.15	0.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	23.96	6.48	2.33	2.07	0.52	0.26	0.39	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.31	11.93	4.07	0.54	2.44	0.54	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.84	6.45	3.50	1.11	0.74	0.55	0.55	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.03	6.80	3.29	1.32	0.44	0.22	1.10	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	44.63	5.95	2.98	3.97	0.99	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	30.87	8.31	3.43	1.19	0.53	0.66	1.06	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	26.83	6.05	2.02	1.21	0.61	0.20	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	107.26	20.08	12.45	5.59	2.54	1.52	0.51	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	14.33	4.58	0.60	1.39	0.40	0.00	0.20	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	8.32	4.47	1.23	0.15	0.15	0.15	0.62	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.87	3.68	1.64	1.23	0.61	0.20	0.61	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.70	4.38	1.88	0.63	1.25	0.00	0.63	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	5.93	0.85	0.28	0.85	0.28	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	12.45	4.15	1.38	0.92	0.92	0.00	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	7.42	2.47	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	14.70	5.03	1.16	0.77	0.39	0.00	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	6.42	0.00	0.00	0.00	0.00	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	6.96	3.48	1.74	1.74	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	14.65	3.25	1.95	0.65	0.33	0.00	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.06	4.94	1.65	0.00	1.65	0.41	0.41	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	18.74	6.43	0.84	0.84	1.12	0.00	0.56	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.00	6.21	0.65	0.33	0.65	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	12.58	2.52	0.84	0.84	0.00	0.00	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.22	6.36	2.23	1.27	1.27	0.64	0.32	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	18.34	4.42	1.70	0.34	0.34	0.00	0.34	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	8.35	2.09	2.09	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	29.78	7.45	2.29	1.72	1.72	0.00	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	12.73	5.03	1.48	1.18	0.30	0.59	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	28.80	3.39	1.69	1.69	0.00	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	28.58	10.77	2.49	1.66	1.66	0.00	1.66	2.07	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	27.16	8.05	3.45	2.30	1.15	0.00	0.69	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	15.81	5.27	0.00	5.27	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	24.22	6.92	3.08	1.15	0.00	0.77	0.38	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.69	6.19	6.19	1.63	0.33	0.00	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	29.43	6.02	4.01	0.67	0.67	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.07	8.48	1.93	0.77	0.00	0.39	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.76	7.19	4.79	1.37	1.37	1.71	1.37	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	7.45	0.00	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	42.94	8.97	0.94	1.89	0.47	0.94	0.47	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	37.42	7.24	3.02	2.41	1.21	1.21	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	33.57	5.60	2.03	1.02	0.51	0.00	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	40.28	7.18	4.79	0.80	2.39	0.80	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.38	6.91	1.48	0.49	0.00	0.99	0.99	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	38.95	8.26	7.08	0.00	0.00	1.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.67	7.58	2.33	2.92	0.58	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	41.69	10.09	2.19	0.88	0.44	0.44	0.88	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	30.52	6.78	0.85	0.00	0.00	0.85	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	36.41	10.15	4.18	2.39	1.19	0.60	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	8.25	2.43	0.97	1.46	0.49	0.49	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	45.65	18.26	4.57	2.28	1.14	3.42	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.98	17.88	5.41	4.57	1.66	0.83	1.66	1.66	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	43.85	21.36	11.24	3.37	5.62	2.25	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	95.47	13.00	5.07	6.98	2.22	0.95	1.59	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	83.97	11.28	7.10	5.43	2.09	1.25	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	56.63	23.21	8.36	2.79	4.99	1.28	2.32	0.46	1.86
Hep-2 cells mock treated, biol_rep2	11899-125E9	56.55	20.42	8.61	2.87	5.06	1.35	2.36	0.84	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	46.64	15.24	5.46	2.05	3.41	1.14	2.05	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	53.12	20.55	7.98	2.62	5.90	0.87	1.75	0.44	1.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	50.72	20.85	7.31	1.72	3.44	0.86	1.72	0.64	1.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	38.10	12.70	6.24	1.72	3.01	1.08	1.94	0.00	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	50.06	18.18	10.21	1.49	3.74	0.50	2.37	0.50	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	48.38	17.33	9.26	2.57	3.26	0.69	1.37	0.51	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	33.32	12.49	6.41	1.60	2.56	1.60	2.24	0.00	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	26.86	15.67	1.68	0.56	2.24	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.82	16.88	3.90	0.43	1.73	0.43	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	21.15	2.64	2.64	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.57	11.99	5.64	1.06	3.17	0.00	2.12	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	10.90	5.81	0.73	0.73	1.45	0.73	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	40.04	12.59	4.20	1.57	1.57	0.00	0.87	0.35	0.00
Hepatocyte, donor1	11523-119I2	76.27	23.00	7.26	7.26	2.42	3.63	4.84	0.00	0.00
Hepatocyte, donor2	11603-120I1	52.79	21.55	10.77	2.15	1.08	4.31	7.54	1.08	0.00
Hepatocyte, donor3	11684-122I1	45.40	12.88	7.98	1.84	3.07	3.07	11.66	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	1.31	2.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	18.18	11.36	7.69	1.05	2.80	0.17	0.52	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	66.96	19.21	6.04	3.70	2.47	0.96	1.37	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	6.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	2.56	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	0.00	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.63	0.00	0.63	0.00	0.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.65	0.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	3.22	0.00	0.00	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.84	0.00	1.68	0.00	0.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	1.61	0.80	0.80	0.00	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	1.85	1.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.47	1.42	0.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	4.30	0.00	0.00	1.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	2.54	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	1.91	1.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	0.00	0.00	0.00	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.93	0.62	0.00	0.00	0.00	0.00	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	1.39	0.70	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	2.21	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	2.62	0.87	0.00	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	2.25	2.25	0.00	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	0.00	1.07	2.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	4.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.92	0.00	0.00	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	2.11	1.06	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.14	7.51	1.96	0.49	1.06	0.00	0.49	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	3.51	1.76	1.76	0.00	1.76	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	7.10	3.60	1.70	0.19	0.66	0.00	0.47	0.00	0.00
Keratinocyte - oral, donor1	11251-116E9	21.23	7.61	3.41	0.57	0.79	0.23	0.79	0.00	0.00
Keratocytes, donor1	11527-119I6	23.04	19.94	5.50	0.34	1.38	0.34	0.34	0.34	0.00
Keratocytes, donor2	11607-120I5	14.06	7.03	2.34	1.17	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	32.41	6.13	3.56	1.38	0.79	0.20	0.20	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	56.09	21.57	3.24	1.08	0.00	1.08	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	92.38	18.68	4.15	6.46	0.69	1.50	0.46	0.92	0.00
Lens Epithelial Cells, donor3	11690-122I7	56.21	18.97	7.27	2.62	2.62	0.91	2.62	0.40	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	57.63	10.67	5.93	1.54	1.30	0.71	2.37	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.58	9.21	3.07	1.95	1.67	0.56	2.51	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	56.67	12.59	6.14	1.89	1.42	0.31	5.04	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	31.19	2.15	5.38	2.15	1.08	0.54	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.94	4.10	3.78	0.32	1.58	0.00	1.89	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	30.51	7.22	2.48	1.73	0.97	0.43	1.29	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	45.55	9.44	4.51	1.64	1.64	1.23	2.46	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	22.00	4.80	2.28	0.25	1.52	0.00	2.53	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	34.20	7.32	2.25	1.13	1.97	0.70	3.52	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	43.90	10.68	3.16	2.77	2.37	1.19	1.58	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	39.55	8.53	3.68	0.78	1.74	0.39	3.49	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.33	4.26	2.59	1.30	1.48	0.37	2.22	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	41.46	9.41	1.74	3.14	1.39	1.05	1.05	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	41.26	6.20	4.05	0.95	0.95	0.72	2.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	27.47	7.28	2.06	0.69	1.10	0.27	2.20	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	47.73	8.01	4.31	2.77	0.92	0.00	1.54	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.32	6.55	1.87	1.25	0.94	0.31	2.18	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.90	6.22	3.66	0.91	1.46	0.00	3.84	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	38.18	8.56	4.61	0.99	0.33	0.66	2.30	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	21.67	3.22	2.93	0.29	0.59	0.00	2.34	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.67	5.48	3.98	1.00	1.49	0.00	4.48	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	48.98	6.30	3.39	1.45	1.45	0.00	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	42.01	8.08	2.96	1.08	1.89	0.54	1.89	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	36.03	7.27	3.63	1.36	1.82	0.30	2.27	0.76	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.18	4.15	2.59	0.00	1.04	1.04	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	40.62	8.17	6.28	1.68	1.05	0.21	3.56	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	25.86	6.32	4.51	1.35	1.65	0.45	3.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	41.96	6.88	0.69	1.38	0.00	2.06	1.38	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	34.05	7.71	4.52	1.51	1.13	0.56	3.20	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.43	6.68	2.86	0.95	1.17	0.11	3.18	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	35.86	6.78	2.42	2.42	2.91	0.48	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.09	4.96	2.98	0.99	1.98	0.33	4.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.04	5.95	1.98	0.87	0.99	0.50	2.48	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	51.46	11.48	3.70	2.96	0.74	0.37	1.11	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	41.02	7.17	4.20	0.99	0.74	0.25	2.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.59	5.91	1.92	1.37	1.24	0.14	2.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	46.96	9.97	4.50	1.61	0.32	1.29	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.04	7.91	3.65	3.35	1.22	0.61	5.17	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	45.63	9.52	6.16	1.96	2.38	0.84	3.92	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	37.33	6.76	4.62	1.78	1.07	0.71	2.49	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.91	5.82	1.94	0.48	1.45	0.00	3.88	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	15.87	4.98	2.80	0.62	1.40	0.00	1.71	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	33.66	8.24	3.94	1.79	1.79	0.72	2.15	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	27.44	4.57	3.92	0.33	1.63	0.65	1.31	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	16.01	4.47	0.94	0.24	0.71	0.24	2.83	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	51.36	11.26	4.46	2.48	2.23	0.50	1.86	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	16.39	7.68	2.05	0.77	0.26	0.00	3.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.68	5.67	4.18	0.90	0.30	0.00	2.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	4.53	6.80	0.00	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.07	1.53	6.14	1.53	0.77	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.23	3.71	1.48	0.00	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	3.81	2.12	1.27	0.00	0.85	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	3.52	1.41	2.11	0.00	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	2.80	1.87	0.00	0.00	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.12	2.58	0.52	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	3.57	1.19	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	3.85	2.26	1.58	0.45	1.36	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	4.07	1.45	1.16	0.00	1.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	4.05	2.70	2.25	0.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	5.01	2.71	1.76	0.14	0.81	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	1.03	1.54	0.00	1.03	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4.59	1.41	1.41	0.71	0.00	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.00	0.00	2.67	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	4.08	3.06	2.55	0.00	1.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	4.80	2.40	2.13	0.27	1.60	0.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3.78	2.08	1.51	0.38	0.76	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	1.23	2.45	0.00	0.61	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	5.71	0.82	2.45	0.00	0.82	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	3.33	2.29	1.46	0.00	0.62	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.61	3.08	1.12	0.28	0.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	3.09	1.03	1.03	0.00	1.03	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.39	2.03	1.16	0.29	0.87	0.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	2.99	2.09	1.20	0.30	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	4.98	1.66	0.55	0.00	0.55	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	4.95	3.18	2.47	0.35	2.47	0.35	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.06	1.84	1.11	0.00	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	0.00	0.00	0.00	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	4.22	3.84	1.54	0.38	0.00	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5.66	1.13	0.57	0.00	0.57	1.13	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	4.10	2.46	2.46	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	2.71	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	4.31	1.44	0.72	0.72	0.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	4.48	1.49	0.75	0.00	0.75	0.00	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.32	3.34	1.11	0.37	1.86	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.45	3.02	0.43	0.00	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	1.71	0.86	0.86	0.86	0.00	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	4.33	2.33	1.00	1.00	0.67	0.00	0.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	8.45	0.60	2.41	0.60	1.21	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.84	1.42	2.13	0.00	0.00	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.47	2.41	2.06	0.00	1.37	0.00	0.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.05	2.15	2.15	0.00	0.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.04	0.67	2.69	0.67	1.35	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	3.70	2.59	2.59	0.37	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	4.65	8.14	0.00	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	0.00	2.12	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	5.20	2.40	0.40	0.80	1.20	0.00	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	0.73	0.73	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	3.07	2.30	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.95	1.97	3.45	0.00	0.49	0.00	0.00	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	0.94	0.94	0.94	1.88	0.00	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	3.02	4.53	2.01	0.50	0.50	0.00	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	4.96	0.90	0.90	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.68	2.23	1.78	0.45	1.34	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	4.30	2.35	0.78	0.39	1.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.28	1.32	0.66	1.32	1.32	0.00	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.63	2.59	0.00	0.00	1.56	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.88	4.38	0.88	0.44	1.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.71	1.68	1.68	0.00	1.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	5.30	1.32	0.44	0.00	0.88	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	4.63	1.54	2.70	0.39	2.31	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.58	3.04	2.03	0.00	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	2.40	1.92	3.84	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	3.58	3.18	1.99	0.80	0.80	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.90	1.22	0.61	0.00	0.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	2.77	0.69	0.00	1.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	5.32	1.52	1.14	0.76	0.76	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	1.55	3.10	1.03	0.52	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	1.81	1.81	0.00	0.60	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3.80	3.17	1.90	0.00	0.95	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	4.26	2.13	2.13	0.00	1.07	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	5.75	2.87	0.57	0.57	1.72	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.26	2.06	0.51	0.00	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.24	3.54	2.83	0.00	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	3.97	1.13	1.13	0.57	0.57	0.00	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	4.16	3.74	2.50	0.42	1.25	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	1.57	4.70	1.57	1.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.10	1.25	1.25	0.84	0.42	0.42	1.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.97	3.25	1.86	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	3.35	1.34	0.00	0.67	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	5.88	3.74	0.53	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.68	3.23	1.21	0.40	1.21	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	2.75	7.34	0.00	0.92	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	2.67	0.00	0.89	2.67	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.84	1.14	1.71	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.83	3.07	2.30	0.77	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.21	2.19	0.55	0.00	1.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.35	3.56	2.67	0.00	1.78	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	6.76	5.20	2.08	0.26	1.30	0.26	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	9.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	4.79	2.05	0.23	0.00	0.91	0.00	0.23	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	6.06	1.84	0.18	0.37	0.92	0.00	0.18	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	3.41	2.10	1.05	0.00	0.26	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	26.02	7.97	3.72	2.12	2.12	0.53	1.06	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	43.42	8.71	2.69	2.38	2.06	0.63	0.63	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	31.55	6.95	3.61	2.08	1.39	0.69	0.69	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	21.82	5.48	3.89	1.10	1.40	0.00	0.90	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	19.40	5.79	2.90	0.29	0.58	0.29	0.58	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	10.23	6.49	6.24	0.50	0.50	0.00	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	8.14	0.68	0.68	1.36	0.00	0.00	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	6.06	2.05	0.54	0.32	0.43	0.22	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	16.64	5.35	0.59	0.59	0.30	0.30	1.78	0.00	0.00
Mast cell, donor3	11566-120D9	28.37	4.95	1.80	1.58	0.90	0.00	2.48	0.23	0.00
Mast cell, donor4	11567-120E1	10.11	3.55	1.95	0.53	0.53	0.18	1.60	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	7.76	1.33	0.78	0.22	0.44	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	7.00	0.00	0.58	0.00	0.58	0.00	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	6.42	1.61	0.80	0.34	0.34	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	4.69	2.18	0.17	0.50	0.33	0.17	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	83.58	21.59	10.45	3.18	2.98	1.19	0.50	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	36.68	12.81	5.54	3.11	0.69	0.00	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	46.72	10.29	4.35	3.91	1.52	0.29	0.43	0.29	0.00
Melanocyte - light, donor1	11274-116H5	14.10	6.11	2.12	0.47	2.35	0.71	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	9.55	4.78	2.05	1.36	1.36	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	10.41	3.47	5.20	1.73	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.45	4.48	1.67	1.04	1.04	0.10	0.42	0.00	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	16.94	6.99	1.61	1.61	1.88	0.00	0.54	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	24.37	4.02	2.14	1.61	1.34	0.54	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	87.96	44.17	5.83	4.09	6.95	0.50	2.23	0.74	0.12
Meningeal Cells, donor2	11573-120E7	42.69	31.25	7.04	0.88	4.40	0.44	5.28	0.44	0.00
Meningeal Cells, donor3	11654-122E7	162.11	40.26	13.94	5.79	5.95	1.22	2.20	0.82	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	142.58	19.68	11.12	6.84	2.85	0.29	1.43	1.71	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.48	9.76	4.03	2.52	2.11	0.70	2.31	0.40	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	6.57	1.31	3.94	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	6.54	2.62	0.00	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	57.41	17.94	5.74	2.15	1.44	0.00	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	134.90	28.59	8.89	8.26	4.45	2.96	4.24	0.85	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	119.13	19.60	6.53	7.04	1.01	4.02	4.02	0.50	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	30.33	19.34	5.71	0.88	2.42	1.76	0.88	0.88	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	30.68	17.53	6.58	0.73	2.19	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.21	16.16	5.32	1.02	1.23	0.82	0.82	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	168.01	19.67	3.32	12.60	1.94	3.32	0.97	1.66	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.41	5.20	3.72	0.00	0.74	0.00	1.12	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	75.26	13.82	7.76	3.55	2.89	0.39	1.18	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.79	4.75	4.45	0.59	1.78	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	7.01	4.67	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.05	17.29	6.40	1.92	0.64	0.00	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	87.19	25.17	9.92	8.51	3.54	0.71	2.84	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	51.91	9.07	7.19	3.44	1.88	0.63	0.63	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	42.09	10.16	5.08	0.73	0.73	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	63.11	17.77	8.22	5.57	3.71	1.06	2.12	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	53.55	16.52	6.51	4.00	2.50	1.00	3.50	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	41.48	11.78	5.85	3.11	1.59	0.58	2.10	0.43	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	1.35	2.70	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	6.65	3.69	2.46	0.25	0.99	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.77	2.06	1.47	0.29	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.20	4.34	1.55	0.31	1.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.22	2.90	1.04	0.00	0.21	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.51	2.25	1.25	1.00	0.00	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	4.19	3.26	0.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.49	2.24	0.81	0.00	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	6.34	3.17	0.40	0.00	0.40	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	5.31	2.65	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	1.14	1.52	0.38	0.76	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.03	2.33	0.00	0.21	0.42	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.92	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	2.09	0.60	0.60	0.00	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	0.00	0.00	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.77	2.26	0.00	0.25	0.00	0.00	0.50	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.23	2.14	0.00	0.00	0.48	0.00	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	1.11	0.00	0.00	0.55	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.07	1.38	0.69	1.15	0.23	0.23	1.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	4.21	2.31	0.21	0.21	0.21	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	1.02	0.61	0.20	0.41	0.41	0.00	1.43	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.93	3.00	0.43	0.64	0.00	0.00	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	4.45	1.56	0.00	0.22	0.00	0.00	1.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.60	0.88	0.22	0.00	0.00	0.00	0.66	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	2.03	0.00	0.00	0.00	0.00	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.99	1.36	0.27	0.27	0.00	0.27	1.36	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	4.41	2.35	0.59	0.29	0.00	0.00	2.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.88	0.48	1.44	0.48	0.00	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	1.20	0.80	0.00	0.40	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00	0.00	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2.50	1.00	1.50	0.00	0.00	0.00	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.07	1.75	0.00	0.00	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.64	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.96	1.49	0.74	0.50	0.50	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	1.39	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2.39	1.71	0.68	0.34	0.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	3.06	0.00	0.00	0.00	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.36	0.71	1.07	0.00	0.00	0.00	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	1.96	1.12	0.28	0.00	0.28	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.33	1.66	0.42	0.00	1.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	4.83	3.02	0.30	0.00	0.00	0.00	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.43	4.17	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	3.69	1.85	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2.85	1.71	0.00	0.00	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	1.80	0.97	0.41	0.14	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.63	2.33	0.52	0.00	0.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.57	3.43	0.43	0.00	0.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	0.64	0.64	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.94	3.74	0.27	0.00	0.80	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	7.78	2.99	0.00	0.30	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	1.98	1.13	0.42	0.00	0.14	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	3.19	3.50	0.96	0.00	0.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	3.32	2.43	0.44	0.66	0.22	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.76	1.14	0.38	0.00	0.76	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.11	3.41	0.57	0.28	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5.41	2.70	0.49	0.00	0.25	0.00	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.65	1.96	0.00	0.00	1.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	7.35	3.53	1.18	0.00	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	7.50	5.19	0.86	0.29	0.00	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	2.47	0.82	0.82	0.00	0.41	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	4.47	1.49	0.89	0.00	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	5.35	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.90	2.96	1.64	0.66	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	2.10	3.16	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.94	2.97	1.38	0.20	1.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	2.79	0.93	1.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	9.01	5.63	0.75	1.50	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	2.66	2.93	0.80	0.27	0.80	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	3.05	1.81	0.45	0.57	0.11	0.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	3.68	5.16	0.74	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.40	2.93	0.73	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	12.44	1.56	0.00	0.00	3.11	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.81	2.14	0.00	1.07	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	0.00	2.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	1.69	0.84	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	4.09	0.00	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	3.24	0.81	0.00	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	1.51	0.00	1.51	0.00	0.00	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	13.05	0.00	6.52	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	178.60	45.24	9.91	14.87	2.37	2.59	0.86	3.02	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	89.89	24.04	4.70	1.57	1.57	5.75	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	41.38	6.67	1.33	2.00	2.67	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.13	10.43	5.84	0.00	0.42	1.67	2.50	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	128.54	26.62	4.18	11.60	0.00	2.66	1.33	1.71	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	97.35	22.34	7.98	3.19	4.79	3.19	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	16.32	3.40	0.68	0.68	0.00	0.00	2.04	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	650.53	106.58	31.24	40.43	14.70	7.35	3.68	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	33.90	3.77	3.35	3.35	0.84	1.67	1.26	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	59.74	11.16	3.49	2.79	0.46	2.32	1.39	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	35.13	11.35	1.89	2.97	0.27	1.62	0.00	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	84.09	16.19	6.94	5.47	1.05	3.78	1.68	2.10	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1837.23	178.16	55.67	89.08	22.27	22.27	0.00	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	66.02	12.41	3.47	5.96	1.99	1.49	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	71.19	9.47	2.71	4.06	0.81	1.35	1.08	2.17	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	59.39	10.65	5.67	5.67	1.13	2.27	1.13	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	38.38	10.61	2.12	3.10	0.33	1.47	0.16	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	90.76	17.31	6.01	8.93	1.46	2.55	1.64	2.73	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	62.59	7.96	4.24	4.24	0.53	3.71	2.12	1.06	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	55.23	6.00	1.20	0.60	0.60	0.00	1.20	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	182.79	16.41	5.58	8.20	0.66	4.59	3.94	3.61	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	36.27	6.50	3.42	2.11	0.81	0.81	1.30	0.81	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	82.90	20.99	6.17	6.53	2.47	3.53	2.65	2.29	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	43.60	8.44	4.22	4.92	0.70	1.41	0.70	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	34.94	4.14	3.68	2.76	0.46	1.84	4.14	1.84	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	40.17	6.43	3.21	4.18	0.32	1.61	1.61	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	186.58	21.73	8.28	18.97	1.72	4.83	4.83	2.07	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	829.33	212.39	35.40	30.34	0.00	10.11	5.06	17.70	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	68.39	18.71	4.90	3.79	0.67	3.12	2.45	1.78	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.56	8.04	2.12	2.12	0.42	0.42	1.27	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	57.68	8.78	3.09	4.03	0.47	1.42	0.95	1.90	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	34.34	4.29	4.29	2.58	0.00	1.29	0.43	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1968.05	207.64	36.11	90.28	0.00	27.08	9.03	27.08	63.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.99	8.66	1.67	2.00	0.33	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	41.93	12.62	3.16	2.71	0.45	3.16	4.06	2.71	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	49.20	7.54	2.38	1.98	0.79	2.78	0.79	1.19	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	45.50	2.79	2.79	2.79	0.00	0.00	2.79	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	39.35	6.81	2.27	4.16	0.38	1.14	0.76	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	25.09	3.58	2.93	1.30	0.00	0.65	1.96	0.98	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.69	4.79	2.18	0.44	0.00	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	66.03	16.73	4.98	4.52	1.36	3.62	1.81	2.71	3.17
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	33.51	9.70	2.65	4.41	0.00	0.88	0.00	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	47.87	6.65	2.66	3.99	0.00	1.33	0.00	1.99	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	33.73	6.45	0.99	3.47	0.50	0.50	0.50	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	24.50	1.15	1.53	1.15	1.15	0.38	0.77	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.31	11.19	0.60	1.51	0.30	0.00	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	64.32	12.38	2.43	5.53	1.99	2.21	0.88	2.21	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.17	6.10	0.00	0.68	0.00	0.68	0.68	0.68	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	679.57	143.07	20.44	76.64	15.33	5.11	0.00	15.33	25.55
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.22	1.22	1.22	1.22	1.83	0.61	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.96	3.46	1.57	1.26	0.31	0.00	0.00	0.63	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.53	5.75	1.82	0.30	0.30	0.61	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	44.30	6.33	0.79	4.75	1.58	0.00	0.79	0.79	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	123.57	20.41	5.67	9.07	1.13	1.13	0.00	2.27	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	703.05	207.37	35.41	106.22	5.06	15.17	5.06	20.23	20.23
Myoblast, donor1	11241-116D8	118.14	37.02	8.32	8.32	3.48	2.86	0.87	1.49	2.98
Myoblast, donor2	11322-117D8	70.96	17.64	6.90	4.99	3.26	1.34	1.73	0.58	0.38
Myoblast, donor3	11398-118D3	164.13	40.02	13.62	14.46	4.88	2.69	2.52	2.02	1.85
NK T cell leukemia cell line:KHYG-1	10777-110G3	1.46	0.58	1.02	0.15	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	17.84	6.15	2.46	1.85	1.23	0.92	4.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	12.36	7.54	3.62	1.51	0.90	0.30	15.98	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	14.91	6.44	2.58	1.84	0.55	0.74	16.75	1.66	0.00
Neural stem cells, donor1	11275-116H6	135.01	25.04	8.35	5.81	0.73	2.54	0.73	2.54	0.00
Neural stem cells, donor2	11352-117H2	105.91	23.11	9.63	3.85	0.00	3.85	7.70	0.00	0.00
Neurons, donor1	11494-119E9	62.58	15.93	0.00	6.83	0.00	2.28	5.69	1.14	0.00
Neurons, donor2	11574-120E8	68.47	15.85	6.83	5.72	3.52	0.66	2.86	0.88	0.00
Neurons, donor3	11655-122E8	79.75	6.58	4.11	8.22	0.82	2.47	4.11	3.29	0.00
Neutrophils, donor1	11233-116C9	7.42	1.86	0.00	0.00	0.93	0.00	13.92	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	2.90	0.00	0.00	0.00	0.00	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	3.05	1.83	0.00	0.00	0.00	0.61	8.55	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	113.63	24.46	8.07	3.92	1.78	0.47	0.95	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	51.77	13.68	5.21	2.93	0.98	1.30	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	76.81	14.84	2.81	2.41	0.80	0.60	1.40	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	103.93	13.49	7.98	5.23	1.38	2.06	1.38	1.79	1.79
Olfactory epithelial cells, donor2	11934-125I8	175.14	20.12	10.57	10.57	2.89	5.21	1.45	3.33	3.47
Olfactory epithelial cells, donor3	11935-125I9	138.59	19.98	9.31	8.51	1.59	5.33	1.36	2.16	2.50
Olfactory epithelial cells, donor4	11936-126A1	116.88	16.07	6.53	7.99	1.95	4.48	1.46	3.80	3.51
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	8.43	6.02	3.01	3.61	0.00	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	54.02	12.97	4.68	4.04	0.85	1.28	1.28	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	13.72	3.43	4.57	2.29	2.29	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	34.76	6.83	7.45	0.00	1.24	0.62	1.24	0.62	0.00
Osteoblast, donor1	11277-116H8	74.27	23.06	4.89	5.67	2.15	1.37	2.35	0.39	0.78
Osteoblast, donor2	11354-117H4	159.43	27.39	9.13	13.34	3.51	5.62	2.81	0.70	0.00
Osteoblast, donor3	11426-118G4	55.27	19.02	9.95	1.96	1.96	1.42	3.20	1.07	0.36
Pancreatic stromal cells, donor1	11249-116E7	207.64	44.22	12.13	13.48	2.86	2.70	1.43	1.43	0.59
Pericytes, donor1	11491-119E6	8.46	13.69	1.67	0.22	1.45	0.00	0.56	0.00	0.00
Pericytes, donor2	11571-120E5	14.26	17.88	2.26	0.91	1.58	1.58	0.23	1.58	0.45
Pericytes, donor3	11652-122E5	23.80	9.97	4.88	0.81	1.83	1.02	1.83	0.20	0.00
Perineurial Cells, donor1	11499-119F5	104.09	21.13	6.44	6.78	3.05	1.13	1.36	0.45	0.34
Perineurial Cells, donor2	11579-120F4	57.14	21.53	8.47	1.75	2.48	0.18	1.38	0.09	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	15.62	5.10	2.23	1.27	0.32	0.32	1.59	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.61	2.94	0.73	0.24	0.98	0.24	6.61	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.15	4.40	2.85	0.39	0.13	0.13	4.40	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	9.09	7.41	0.96	0.48	1.43	0.00	2.87	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	34.38	4.44	2.22	1.11	0.00	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	14.14	6.68	4.32	1.37	2.16	0.00	1.18	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	73.10	11.08	5.38	7.28	1.90	1.27	0.32	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	93.04	15.94	8.07	4.50	2.44	1.31	1.13	0.75	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	55.60	19.45	7.44	3.79	2.09	1.17	0.39	0.26	0.78
Preadipocyte - breast, donor2	11328-117E5	73.62	16.21	8.78	5.40	3.83	1.58	0.68	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	101.98	25.25	7.46	8.31	3.94	1.70	1.17	1.49	1.07
Preadipocyte - omental, donor2	11329-117E6	114.36	17.90	3.06	10.04	4.36	2.62	0.44	1.75	0.87
Preadipocyte - omental, donor3	11403-118D8	66.90	18.91	10.31	2.72	2.58	1.00	0.57	0.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	41.34	8.86	0.00	2.95	0.98	0.98	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	30.40	14.74	4.30	1.84	2.15	0.31	2.46	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	109.43	32.94	10.62	2.66	4.43	0.53	5.14	0.71	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	57.22	16.69	11.24	1.70	2.38	0.85	3.07	0.68	0.00
Preadipocyte - visceral, donor1	11280-116I2	191.88	48.62	10.99	7.27	4.28	1.68	2.14	1.12	0.37
Preadipocyte - visceral, donor2	11357-117H7	104.46	31.29	8.28	2.30	4.14	0.92	0.92	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	89.97	26.02	5.12	4.70	3.55	1.46	1.67	0.52	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	14.48	7.09	4.53	0.75	4.37	0.00	0.15	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	6.36	1.90	1.22	0.00	0.41	0.00	0.41	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	9.37	4.59	4.35	0.55	1.71	0.00	0.61	0.00	0.06
Prostate Stromal Cells, donor1	11254-116F3	100.12	22.78	8.88	5.47	3.76	1.48	2.39	1.03	0.57
Prostate Stromal Cells, donor2	11332-117E9	100.59	22.41	10.58	2.51	3.59	1.79	1.97	0.72	0.36
Prostate Stromal Cells, donor3	11405-118E1	76.02	18.35	9.18	4.59	2.50	1.46	2.19	1.04	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	8.39	1.82	0.00	0.73	0.00	1.46	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	55.17	10.95	3.47	2.01	1.39	0.42	0.69	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	8.12	12.68	7.10	0.51	1.52	0.00	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	7.11	9.25	1.42	0.71	1.42	0.00	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	62.14	9.74	4.02	3.60	1.48	0.42	1.06	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	13.62	2.72	0.00	2.72	0.68	0.00	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	32.88	13.34	4.31	1.48	2.29	0.81	0.94	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	58.61	20.42	4.00	3.33	1.11	0.67	0.67	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	7.32	1.33	0.00	0.67	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	19.81	12.99	1.76	1.32	0.88	0.00	1.32	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	16.30	12.54	5.64	0.63	1.88	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.49	6.94	1.94	0.28	1.11	0.55	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.99	22.55	4.29	0.81	2.68	0.00	0.00	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.01	11.39	4.22	0.42	0.42	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.86	19.09	3.47	0.96	1.93	0.19	0.39	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	131.97	29.56	5.70	12.45	0.00	2.07	1.04	1.81	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	28.71	11.94	3.70	2.84	0.28	1.14	0.28	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	12.35	7.20	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	93.34	14.30	3.51	4.77	2.01	0.75	0.50	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	81.12	21.52	11.36	6.01	4.68	2.14	0.67	0.53	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	66.11	17.87	5.36	9.83	3.57	1.79	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	160.71	18.71	4.40	8.26	1.10	3.85	0.55	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	133.99	23.78	7.54	11.02	1.16	2.32	0.58	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	128.33	32.12	5.85	7.15	5.59	2.73	0.52	1.82	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	77.56	24.13	11.52	4.87	2.78	1.09	0.10	1.49	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	136.41	33.46	13.83	9.37	4.46	2.45	0.56	0.45	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	163.99	47.63	10.30	14.14	3.85	3.47	0.37	1.49	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	91.37	24.47	11.19	4.43	3.03	1.86	0.35	0.35	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	113.95	29.35	11.09	6.01	5.08	2.31	0.00	1.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	77.08	24.64	5.89	4.24	3.29	2.33	0.14	0.96	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	89.10	23.14	9.98	4.84	3.93	1.82	0.15	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	87.80	27.42	9.68	6.81	3.58	2.87	0.54	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	83.06	27.54	6.17	5.59	4.30	2.15	0.43	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	84.89	27.26	9.44	4.72	4.08	1.72	0.32	0.64	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	79.44	23.68	10.84	4.65	3.54	1.99	0.22	1.11	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	84.12	23.32	9.18	5.93	1.34	4.21	0.38	1.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	84.96	23.10	9.50	5.59	4.10	1.77	0.47	1.02	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	177.38	45.85	13.34	9.96	4.32	3.01	0.56	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	84.40	26.41	4.78	4.38	4.91	4.51	1.46	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	86.44	26.28	11.58	4.77	4.28	1.17	0.29	0.97	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	103.31	27.50	12.41	5.73	6.11	2.10	0.57	1.53	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	85.97	25.20	4.91	5.45	4.27	2.24	0.64	1.17	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	93.90	24.39	8.97	6.17	2.24	2.24	0.84	1.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	89.89	25.81	9.40	4.10	4.27	2.22	0.17	1.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	82.96	25.89	3.46	3.46	4.56	1.82	0.36	1.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	84.25	21.71	8.09	5.89	2.08	2.21	0.37	1.35	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	87.71	27.13	11.01	5.24	3.49	2.82	1.21	1.48	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	97.65	29.25	7.31	7.55	3.54	2.83	0.47	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	96.83	26.79	9.52	6.55	2.58	1.79	0.20	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	92.37	24.79	10.52	4.91	3.98	1.17	0.47	1.17	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	90.20	26.96	6.84	4.56	3.94	4.56	1.04	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	125.20	28.31	7.74	6.86	3.32	2.43	0.88	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	71.02	22.14	12.12	3.55	2.72	2.09	0.21	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	94.21	31.49	7.00	5.11	4.04	3.63	1.08	1.48	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	88.04	25.71	10.56	5.28	4.60	2.04	1.19	1.19	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	76.73	26.80	15.23	3.86	4.63	2.12	0.58	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	102.99	30.95	9.97	7.22	3.27	4.30	0.17	1.20	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	75.44	25.10	11.93	4.12	3.43	1.92	0.55	1.10	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	101.62	26.10	11.82	5.75	3.45	2.30	0.99	0.99	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	82.49	25.22	3.58	5.11	2.56	2.05	1.02	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	100.61	27.52	13.91	5.03	4.88	1.63	0.30	1.18	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	79.70	24.52	9.60	4.26	3.20	2.67	0.80	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	71.35	17.70	3.73	3.46	2.07	1.66	0.14	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	80.00	21.67	9.05	3.81	2.86	1.67	0.00	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	93.92	27.41	13.91	4.43	4.43	3.02	0.00	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	79.86	24.39	4.14	4.24	3.30	1.98	0.28	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	111.45	21.66	13.28	5.94	1.40	3.14	1.05	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	77.67	15.72	9.67	4.23	1.81	2.12	2.12	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	71.72	24.72	5.51	3.92	3.55	0.98	0.24	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	170.01	28.24	9.90	12.23	3.20	2.47	0.73	1.31	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	97.35	18.25	5.48	4.26	1.83	1.22	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	70.53	19.59	6.63	4.52	3.62	2.41	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	61.98	15.38	7.69	4.52	2.71	0.90	1.13	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	79.68	15.28	6.29	3.59	3.00	1.20	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	82.18	21.73	4.60	4.96	3.31	1.77	1.18	1.06	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	60.83	13.87	7.26	3.20	2.77	0.85	0.64	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	83.54	17.43	9.62	4.81	1.20	4.81	0.60	0.00	0.00
Schwann Cells, donor1	11498-119F4	21.06	24.45	2.63	0.56	2.63	0.94	0.56	0.56	0.00
Schwann Cells, donor2	11578-120F3	81.66	10.21	6.80	3.40	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	65.07	17.96	3.72	1.53	1.31	0.66	1.75	0.66	0.00
Sebocyte, donor1	11220-116B5	32.87	15.34	6.03	1.10	2.74	0.00	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	7.81	6.43	1.84	0.00	0.92	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	24.12	7.01	4.12	1.44	0.82	0.21	0.21	0.21	0.41
Sertoli Cells, donor1	11255-116F4	107.68	19.88	18.22	6.63	4.97	8.28	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	70.61	22.59	2.82	8.47	2.82	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	68.09	19.44	7.65	6.07	1.85	1.41	2.20	1.76	0.70
Skeletal Muscle Cells, donor2	11358-117H8	28.19	18.07	4.34	2.89	0.72	0.72	1.45	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	21.74	36.79	5.85	1.67	0.84	1.67	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	88.92	22.46	4.08	5.81	3.14	2.20	3.93	0.94	0.16
Skeletal Muscle Cells, donor5	11455-119A6	77.44	20.22	4.31	4.01	3.27	1.64	3.57	0.74	0.30
Skeletal Muscle Cells, donor6	11459-119B1	119.74	26.93	4.62	8.62	3.39	3.69	3.08	2.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	177.42	27.34	10.21	9.20	3.02	1.39	1.39	1.51	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	99.74	22.83	5.99	6.42	2.43	2.43	2.57	1.71	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	103.58	30.36	9.92	4.37	3.37	3.27	4.56	1.59	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	122.42	39.68	9.86	10.78	2.53	2.95	3.62	2.61	4.47
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	23.88	2.90	3.62	0.72	1.45	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	30.82	13.62	3.72	1.38	2.20	0.96	2.89	0.41	0.00
Skin - palm, donor1	10286-104F7	16.12	0.00	5.37	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.32	1.15	0.72	0.00	0.14	0.14	0.43	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	7.36	2.45	0.00	0.82	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.28	1.56	0.65	0.39	0.13	0.00	0.13	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	8.90	2.78	1.25	0.56	0.70	0.14	1.39	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	4.64	1.69	1.13	0.42	0.70	0.14	0.98	0.00	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	8.03	1.90	1.69	0.85	0.85	0.00	0.85	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	4.72	2.02	2.55	0.15	1.20	0.00	1.35	0.07	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	71.28	20.68	4.63	1.23	1.23	4.01	0.62	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	32.68	10.23	1.33	1.33	1.33	0.44	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	42.91	8.82	4.70	1.76	1.18	1.18	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	23.43	13.26	5.08	1.55	1.99	0.22	1.10	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	39.38	22.45	3.15	2.36	1.18	0.79	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.99	20.86	6.95	3.86	0.00	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	96.07	7.01	10.01	3.00	2.00	2.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	34.87	15.97	5.72	1.86	1.60	0.53	0.53	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	63.61	11.08	6.65	3.32	1.99	0.44	0.66	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	57.49	12.16	3.33	2.18	1.15	0.90	1.28	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	109.07	22.79	10.09	5.86	1.63	2.28	0.98	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	116.36	30.71	6.79	7.97	2.36	0.89	3.25	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	57.09	16.66	6.98	3.27	1.28	1.57	1.28	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	24.73	27.65	7.16	1.63	3.25	0.65	1.30	0.65	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	48.10	11.57	9.74	2.13	1.83	0.61	1.83	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	38.14	11.62	5.56	2.02	3.54	0.00	2.53	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	13.83	2.38	1.43	1.91	0.00	1.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	122.55	20.35	5.31	9.44	1.92	2.06	1.77	0.44	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	73.40	16.57	4.74	6.24	1.08	1.08	1.51	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	75.78	20.89	7.66	4.20	2.52	1.26	1.15	0.73	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.58	19.64	5.41	3.25	1.86	1.08	0.46	0.00	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	7.55	0.00	1.08	1.08	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	33.77	14.35	4.18	1.20	3.89	0.60	0.60	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	13.66	12.97	3.41	1.02	4.10	1.37	1.02	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	131.07	18.93	8.64	4.63	2.59	1.18	1.49	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	60.59	18.01	6.94	1.51	2.21	0.70	0.40	0.10	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	41.64	21.85	8.42	2.05	1.37	0.23	1.14	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	25.36	19.93	3.02	2.42	1.81	0.00	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	122.66	23.05	8.74	6.09	2.12	1.59	1.85	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	123.97	26.37	6.52	7.46	5.06	1.07	1.33	0.53	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	62.48	22.66	8.01	2.75	1.63	0.13	0.63	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	124.55	19.28	8.62	7.10	2.54	1.27	1.78	1.01	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	77.05	15.98	8.74	2.41	3.32	0.90	1.21	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.75	11.25	9.00	0.75	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	51.69	5.17	0.00	1.29	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.09	13.49	5.58	1.86	1.40	0.47	3.26	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	29.79	11.11	8.58	1.01	1.01	0.50	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.21	13.48	2.19	0.94	2.51	0.63	1.57	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.56	14.16	5.60	1.18	1.47	0.59	1.47	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	111.96	27.99	9.50	5.33	4.83	0.83	2.67	0.67	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	79.42	15.88	7.47	1.40	3.27	0.00	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	47.78	22.31	6.33	3.45	1.73	1.44	0.72	0.29	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	41.81	19.63	9.18	2.80	2.80	1.02	1.78	0.51	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.77	16.55	4.14	1.13	1.88	0.38	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	188.52	28.37	9.08	13.42	2.66	3.21	1.26	1.26	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	131.38	19.69	6.28	9.64	2.51	2.85	2.01	0.92	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.57	4.29	3.33	0.95	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	43.06	16.88	7.83	2.45	2.45	1.22	1.47	0.00	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	83.74	17.01	4.64	5.97	3.09	1.77	3.98	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	154.77	24.58	7.31	6.73	2.34	1.46	1.46	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.40	8.75	3.50	2.14	0.19	0.78	0.39	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	91.50	15.60	5.82	7.67	1.59	3.70	1.06	2.12	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	123.49	17.11	3.35	9.67	0.74	1.86	0.00	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	127.56	26.95	3.23	11.86	1.08	5.03	0.72	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	71.26	28.67	5.96	5.96	0.57	4.54	0.85	3.12	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	124.46	26.39	5.12	10.63	0.79	1.58	0.00	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	76.19	14.22	5.59	3.81	1.78	0.76	0.00	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	45.52	11.18	4.39	3.99	0.80	0.00	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	68.55	12.96	3.34	5.43	0.84	1.25	0.00	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	51.34	9.63	7.79	0.46	2.29	0.46	0.92	0.46	0.00
Synoviocyte, donor1	11291-117A4	141.22	25.42	8.08	7.74	2.52	2.86	2.36	1.85	2.19
Synoviocyte, donor2	11368-117I9	65.71	12.74	9.72	4.02	1.68	0.67	1.01	0.34	0.67
Synoviocyte, donor3	11440-118H9	55.41	9.83	1.34	3.35	2.46	0.67	0.89	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	14.29	12.51	3.22	1.43	0.71	0.00	0.36	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	11.89	0.00	0.00	1.98	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.21	12.04	4.40	0.23	0.93	0.00	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	9.82	2.51	1.79	0.22	0.57	0.07	0.72	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	5.41	1.55	1.16	0.00	0.39	0.00	1.16	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	1.72	1.72	0.00	0.00	0.00	1.72	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	86.12	15.75	8.61	7.14	4.06	2.46	0.98	0.62	0.25
Urethra, donor2	10319-105A4	116.90	14.39	8.99	12.59	7.19	7.19	0.00	3.60	0.00
Urothelial Cells, donor1	11520-119H8	3.45	3.72	2.13	0.27	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.20	0.80	0.40	0.00	0.40	0.00	0.80	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.75	3.44	1.38	0.00	1.15	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	19.17	4.01	1.56	0.89	0.67	0.00	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	7.12	5.34	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	4.29	0.00	1.43	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	3.42	1.37	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	5.51	2.75	1.38	0.00	0.69	0.00	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	3.49	2.32	1.16	0.00	0.58	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	5.21	6.25	2.08	1.04	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	5.51	5.51	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	6.39	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	31.09	10.12	4.81	0.99	2.34	0.25	0.37	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	31.68	7.04	0.88	1.76	1.76	0.88	3.52	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	19.27	4.47	2.23	0.00	0.84	0.00	1.40	0.56	0.00
achilles tendon, donor2	10292-104G4	28.93	6.20	4.13	6.20	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	11.47	3.82	2.80	0.00	0.25	0.25	0.25	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.59	2.79	0.70	0.46	0.23	0.00	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	12.58	5.46	0.95	1.19	0.59	0.36	0.12	0.24	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	4.08	1.90	1.90	0.27	0.27	0.00	0.27	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	9.56	4.50	1.97	0.00	1.12	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	9.52	4.23	2.96	0.85	0.85	0.00	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	6.53	4.08	1.91	0.00	2.72	0.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	5.29	3.53	1.76	0.44	2.20	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	6.13	1.63	2.04	0.41	0.41	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	3.49	1.94	2.72	0.39	0.39	0.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2.76	1.84	1.29	0.18	1.84	0.18	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	3.90	0.00	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	6.74	4.42	0.46	0.70	0.93	0.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	6.47	3.37	1.81	0.26	0.78	0.26	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	6.72	2.63	1.17	0.29	0.29	0.00	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	3.25	1.39	1.39	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	5.35	3.29	1.65	0.00	0.00	1.23	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.76	1.84	0.92	0.00	0.31	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	8.53	3.41	1.28	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	8.19	5.46	0.91	0.30	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	9.39	6.50	2.89	0.00	0.72	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.35	5.12	2.67	0.00	0.67	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.34	2.33	0.67	0.00	1.67	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	3.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	6.03	3.77	0.75	0.00	0.00	0.00	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	5.67	2.62	3.49	0.00	0.44	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	5.62	1.87	1.87	1.87	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	1.41	1.65	0.24	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	68.87	15.67	8.38	5.74	4.03	0.93	0.62	0.47	0.47
adipose, donor1	10184-103D4	68.02	3.52	3.52	3.52	0.00	0.59	0.00	0.59	0.00
adipose, donor2	10185-103D5	15.82	5.27	2.43	0.81	0.81	0.00	0.41	0.00	0.00
adipose, donor3	10186-103D6	23.42	6.53	2.72	0.27	0.27	0.00	0.27	0.27	0.27
adipose, donor4	10187-103D7	13.87	19.07	6.07	1.73	0.00	1.73	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.20	9.47	8.21	0.47	1.89	0.00	0.95	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	18.19	0.00	14.55	3.64	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.00	1.33	0.67	0.27	0.27	0.27	0.13	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	76.46	14.29	11.79	4.64	2.14	1.43	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	13.91	5.33	5.56	0.93	3.25	0.46	1.39	0.00	0.70
amniotic membrane cells, donor2	12236-129G4	42.26	12.17	8.79	1.35	1.01	0.68	2.70	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	10.61	5.60	5.30	0.88	4.71	0.00	0.29	0.00	0.00
amygdala - adult, donor10196	10167-103B5	62.85	7.11	7.11	13.04	3.56	9.49	4.74	1.19	0.00
amygdala, adult, donor10252	10151-102I7	54.54	11.76	4.46	12.17	2.23	15.82	2.03	6.49	0.00
amygdala, newborn, donor10223	10360-105E9	17.11	9.04	2.26	2.26	0.97	0.65	0.97	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	161.33	29.16	8.28	13.75	2.16	4.33	1.91	2.80	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	2.87	1.54	0.88	0.22	0.44	0.00	0.00	0.66	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	46.43	5.68	1.67	1.00	0.33	1.67	0.67	1.00	0.00
aorta, adult, pool1	10052-101G7	97.67	13.53	7.06	8.63	2.55	1.96	0.59	0.59	1.18
appendix, adult	10189-103D9	49.29	14.75	4.27	5.43	1.94	1.94	1.55	0.78	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	91.14	21.32	6.88	7.91	1.38	3.10	0.34	1.72	0.00
artery, adult	10190-103E1	448.37	103.26	10.87	86.96	8.15	52.99	1.36	16.30	14.95
astrocytoma cell line:TM-31	10425-106D2	166.74	28.68	14.49	14.34	4.20	1.59	1.74	1.74	0.29
b cell line:RPMI1788	10427-106D4	9.67	4.46	1.78	0.00	0.30	0.15	2.38	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	227.78	41.62	17.20	18.03	5.27	4.72	1.94	1.66	3.33
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.24	5.16	2.28	1.59	0.69	0.40	0.89	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	4.69	3.01	2.01	0.67	1.67	0.00	0.17	0.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.80	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	256.28	31.72	16.84	15.97	5.87	6.52	1.96	1.41	3.91
blood, adult, pool1	10053-101G8	4.43	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	97.62	22.27	6.85	6.85	2.57	0.86	2.57	0.86	0.00
bone marrow, adult	10192-103E3	49.26	10.80	5.40	2.70	2.70	2.02	0.00	2.02	0.00
brain, adult, donor1	10084-102B3	56.38	7.18	5.13	11.28	2.05	8.20	1.03	4.10	0.00
brain, adult, pool1	10012-101C3	149.44	20.38	7.13	32.18	4.68	17.82	1.22	10.91	0.22
brain, fetal, pool1	10085-102B4	8.01	2.67	0.00	0.00	2.67	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	0.99	0.66	0.33	0.00	0.66	0.00	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	23.36	11.36	6.31	3.79	0.00	1.26	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.34	3.05	2.92	1.02	1.02	0.00	0.38	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	25.67	10.20	9.59	2.16	3.40	0.00	0.00	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	62.85	22.33	6.22	1.38	3.91	0.23	0.69	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	8.72	6.29	6.29	0.24	1.94	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	36.67	26.80	7.99	1.41	4.70	0.00	1.88	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	6.89	3.83	2.73	0.44	1.20	0.11	0.22	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	54.19	15.53	6.34	2.54	1.58	0.63	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	79.32	18.63	4.79	5.86	2.40	3.19	1.86	3.46	0.00
caudate nucleus - adult, donor10196	10177-103C6	77.14	11.51	3.45	12.66	2.30	21.88	3.45	18.42	0.00
caudate nucleus, adult, donor10252	10164-103B2	44.68	12.05	3.85	9.54	2.68	10.04	8.37	4.02	0.00
caudate nucleus, adult, donor10258	10379-105H1	38.97	9.17	3.82	5.35	2.29	4.58	5.35	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	33.69	9.89	1.83	3.30	0.73	4.39	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	142.75	26.22	8.74	11.65	0.00	11.65	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	122.98	20.28	11.96	15.16	4.48	6.83	1.28	1.71	0.00
cerebellum, adult, pool1	10083-102B2	83.82	20.01	7.24	8.28	2.41	3.45	0.00	2.07	0.00
cerebellum, newborn, donor10223	10357-105E6	82.20	15.78	4.98	12.45	1.66	9.13	0.00	2.49	0.00
cerebral meninges, adult	10188-103D8	68.33	18.41	7.56	11.85	4.03	7.56	1.51	4.03	0.00
cerebrospinal fluid, donor2	10294-104G6	200.26	31.43	11.69	22.66	3.65	20.46	0.73	19.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	23.72	4.60	3.02	0.58	1.58	0.00	0.43	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	46.90	19.06	4.47	3.15	1.82	1.16	0.50	0.33	3.48
cervix, adult, pool1	10013-101C4	127.14	26.46	10.92	10.60	4.93	1.47	2.41	0.52	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	53.37	12.40	6.13	5.57	0.84	2.23	1.81	0.42	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	7.84	5.23	1.31	1.31	0.00	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	11.56	11.18	5.84	0.25	3.85	0.12	0.25	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	23.16	28.59	20.21	0.25	5.05	0.25	0.99	0.12	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	1.42	5.69	6.17	0.00	1.19	0.00	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	11.11	5.70	4.56	1.14	2.28	0.28	2.85	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	68.31	18.30	7.26	4.08	3.38	0.99	1.49	0.20	0.60
chorionic membrane cells, donor3	12240-129G8	11.54	3.85	1.10	1.10	1.65	0.00	1.65	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	5.96	2.50	2.11	0.38	0.19	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	4.65	1.06	0.42	0.42	0.21	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.03	2.57	0.77	0.00	0.77	0.00	0.26	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.45	0.97	0.24	0.00	0.48	0.00	0.24	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.04	1.63	0.61	0.00	0.61	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	5.59	1.18	0.29	0.00	0.29	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	9.64	5.73	3.91	0.78	0.78	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	34.97	14.86	3.89	0.23	1.14	0.69	1.60	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	44.24	8.33	3.64	4.34	0.87	1.91	5.90	0.69	0.17
colon carcinoma cell line:CACO-2	10513-107D9	28.92	17.21	8.79	0.55	3.84	0.00	1.10	0.55	0.37
colon carcinoma cell line:COLO-320	10420-106C6	164.20	37.25	6.84	9.50	2.28	1.52	0.00	1.90	0.00
colon, adult, donor1	10082-102B1	34.51	11.90	1.19	8.33	3.57	3.57	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	87.07	10.93	6.46	12.57	2.59	2.35	1.65	0.12	0.35
colon, fetal, donor1	10070-101I7	88.99	8.65	4.33	16.07	1.85	9.27	0.62	4.94	1.24
common myeloid progenitor CMP, donor1	12130-128D6	9.17	9.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	15.30	6.80	1.70	1.27	0.85	0.42	1.70	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	6.49	2.26	0.15	0.15	0.75	0.00	0.75	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	5.50	3.95	0.56	0.28	0.28	0.14	1.13	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	220.68	39.14	9.51	55.28	5.64	40.36	0.88	20.79	0.33
cruciate ligament, donor2	10295-104G7	51.06	11.35	11.35	3.24	3.24	2.43	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	309.79	60.99	12.84	36.12	9.63	29.69	0.00	18.46	17.66
diencephalon, adult	10193-103E4	102.48	21.84	5.52	26.88	1.20	33.36	2.40	18.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.12	3.44	1.84	0.23	0.23	0.46	0.46	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	10.77	4.62	2.82	0.51	2.31	0.00	1.03	0.26	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	83.29	20.70	8.67	5.54	1.69	0.96	2.65	1.69	0.96
ductus deferens, adult	10196-103E7	73.75	20.93	4.49	7.97	0.00	5.48	0.00	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	4.32	1.44	1.44	1.44	1.44	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	53.70	10.30	6.62	8.09	2.21	2.21	0.00	0.74	2.21
dura mater, adult, donor1	10041-101F5	56.74	11.31	7.35	1.57	2.81	0.58	2.97	0.41	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	79.72	34.64	2.44	4.89	0.67	4.44	1.55	6.88	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	119.51	59.18	7.74	5.16	1.15	1.86	0.57	0.86	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	31.45	9.25	5.55	0.62	0.00	0.00	1.85	2.47	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	40.56	14.83	2.42	0.91	0.30	0.91	1.51	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.71	11.73	3.40	0.93	1.85	0.93	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	35.46	13.13	2.63	1.31	2.63	2.63	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	11.06	4.02	1.01	0.00	0.34	0.00	0.67	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	75.21	22.84	13.41	3.62	4.53	0.36	0.18	0.36	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	22.51	7.24	3.22	1.45	1.61	0.00	0.64	0.00	0.00
epidermoid carcinoma cell line:A431	10426-106D3	13.45	5.56	1.45	0.56	0.78	0.44	3.22	0.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	41.35	16.50	7.59	2.53	2.31	0.88	4.40	0.55	0.22
epididymis, adult	10197-103E8	80.58	21.77	7.33	4.81	2.09	2.93	0.00	1.26	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	127.20	25.72	7.98	8.16	3.73	2.66	2.66	1.24	2.31
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	95.56	36.57	5.11	6.69	0.79	3.54	2.36	2.75	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	50.98	19.92	14.94	2.49	5.11	0.52	0.92	0.39	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	45.08	23.82	15.55	1.77	6.10	0.30	1.28	0.20	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	45.60	22.52	15.57	1.57	4.93	0.78	1.34	0.45	0.22
esophagus, adult, pool1	10015-101C6	129.22	18.26	6.16	16.25	2.23	4.99	0.42	2.02	3.93
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	144.52	24.05	7.39	6.64	1.38	1.88	8.77	1.00	7.39
eye - muscle inferior rectus, donor1	10272-104E2	176.26	21.73	0.00	26.56	0.00	14.49	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	334.57	37.88	6.31	52.61	2.10	37.88	2.10	33.67	4.21
eye - muscle medial, donor2	10299-104H2	153.29	32.74	7.44	11.91	4.46	22.32	0.00	11.91	1.49
eye - muscle superior, donor2	10297-104G9	96.31	21.78	2.29	14.90	4.59	8.03	0.00	2.29	1.15
eye - vitreous humor, donor1	10268-104D7	8.74	8.74	0.00	1.46	2.91	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	65.08	12.97	5.08	10.17	2.54	5.34	0.25	1.53	4.32
fibrosarcoma cell line:HT-1080	10758-110E2	26.80	6.41	5.26	1.03	0.90	0.13	0.13	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	68.85	15.91	4.99	4.99	0.24	0.95	0.00	0.95	0.00
frontal lobe, adult, pool1	10040-101F4	124.79	20.36	7.41	28.62	3.19	19.98	1.78	10.13	0.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	36.63	18.01	8.41	1.80	2.40	0.90	0.90	0.30	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	63.37	7.13	4.21	4.39	1.28	1.37	3.29	0.18	0.00
gall bladder, adult	10198-103E9	47.32	15.93	5.55	5.55	1.21	0.97	0.24	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	12.35	5.37	1.07	0.54	0.00	0.54	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	21.29	7.10	2.61	2.24	1.87	0.75	1.49	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.43	8.45	0.63	1.06	0.00	0.00	0.00	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	1.74	0.97	0.58	0.00	0.00	0.00	0.39	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	60.99	29.18	7.21	2.79	1.97	0.16	0.98	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	43.93	12.81	2.75	0.92	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	34.04	14.16	3.20	3.66	0.46	1.37	0.00	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	8.84	3.44	2.29	0.57	1.26	0.34	0.11	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	121.76	11.76	4.62	7.98	0.84	2.24	0.70	1.26	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	2.74	2.24	2.74	0.50	0.50	0.00	0.25	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	51.83	16.04	3.69	6.12	0.84	1.16	0.00	0.74	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	46.91	12.22	2.11	4.21	0.56	1.69	0.00	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	56.84	5.08	2.54	2.54	0.88	0.44	0.44	0.44	0.00
glioma cell line:GI-1	10413-106B8	39.83	7.03	2.05	2.05	0.88	0.29	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	130.48	15.31	2.92	20.41	0.00	47.38	0.73	20.41	0.00
globus pallidus, adult, donor10252	10161-103A8	160.37	24.41	8.30	53.70	4.15	49.80	0.49	26.12	0.49
globus pallidus, adult, donor10258	10367-105F7	105.43	15.06	2.74	41.08	1.37	23.28	0.00	15.06	0.00
globus pallidus, newborn, donor10223	10364-105F4	52.76	11.72	2.13	4.26	0.53	5.33	1.07	2.66	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	0.00	4.89	0.00	2.45	0.00	2.45	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	45.76	14.40	5.44	2.88	0.96	0.96	1.28	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	15.61	2.75	0.00	1.38	0.00	1.38	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	13.26	3.20	2.29	1.37	0.00	0.91	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	8.37	5.80	0.00	0.00	0.00	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	14.37	1.44	1.44	1.44	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	7.54	2.06	0.69	0.69	0.69	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	83.86	16.55	3.31	11.03	0.00	17.66	0.00	6.62	0.00
hairy cell leukemia cell line:Mo	10712-109I1	4.02	2.30	1.15	0.00	1.15	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	118.09	23.02	5.98	13.15	2.09	4.78	1.20	3.29	4.19
heart - pulmonic valve, adult	10206-103F8	258.34	33.73	12.81	27.19	4.18	9.67	0.26	8.11	3.66
heart - tricuspid valve, adult	10207-103F9	63.28	7.49	2.50	5.83	2.50	2.50	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	104.07	21.43	5.51	9.59	2.24	3.47	1.63	1.02	1.43
heart, adult, diseased, donor1	10051-101G6	188.64	25.55	9.37	13.63	3.41	7.24	1.28	3.41	1.70
heart, adult, pool1	10016-101C7	195.48	31.05	8.97	23.23	2.76	8.28	0.92	5.06	8.74
heart, fetal, pool1	10046-101G1	334.63	43.54	9.34	37.79	4.00	12.01	0.92	8.21	15.30
hepatic mesenchymal tumor cell line:LI90	10778-110G4	97.49	16.66	7.71	10.49	2.16	4.94	1.23	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	4.76	3.57	3.57	1.19	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	128.18	57.57	27.18	3.87	5.75	0.66	0.77	0.55	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	133.75	58.14	25.73	5.58	6.55	0.61	0.85	0.49	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	148.85	72.56	25.57	4.35	5.76	1.41	0.51	0.91	0.00
hepatoma cell line:Li-7	10484-107A7	58.50	15.24	6.01	3.23	2.67	1.89	0.00	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	6.93	3.22	0.70	0.60	0.40	0.10	0.10	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	80.44	7.57	3.79	5.68	0.00	6.62	0.95	8.52	0.00
hippocampus, adult, donor10252	10153-102I9	78.58	15.72	5.92	16.94	4.29	17.76	1.43	6.53	0.20
hippocampus, adult, donor10258	10374-105G5	52.28	5.98	0.00	4.48	0.50	9.46	1.49	4.48	0.00
hippocampus, newborn, donor10223	10363-105F3	22.91	7.05	1.76	2.82	1.76	1.06	1.76	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	25.63	7.93	2.44	0.61	0.61	1.22	0.00	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	14.33	5.69	0.79	1.57	0.39	0.20	0.39	0.79	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	18.28	9.14	0.25	0.51	0.51	1.02	0.51	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	19.17	4.51	0.00	1.13	0.00	0.00	0.56	1.13	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	23.50	3.87	0.26	1.55	0.00	0.52	0.52	0.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	33.41	5.31	2.28	2.28	0.38	0.38	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.57	9.63	3.80	1.17	0.29	0.29	1.17	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.10	5.82	3.88	0.86	1.94	0.22	0.22	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	17.93	7.92	2.50	0.83	1.25	0.00	0.00	1.67	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	48.54	15.63	4.97	3.55	3.08	0.24	1.18	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.57	9.32	4.82	1.61	1.93	0.32	0.32	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	46.46	22.89	2.69	4.04	2.69	1.35	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	10.80	2.50	1.56	0.31	0.94	0.31	0.47	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.28	3.93	0.98	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.07	4.36	0.00	0.87	0.87	0.87	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	26.54	3.63	1.15	0.57	0.95	0.38	0.38	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	21.80	3.49	0.00	0.00	0.44	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	39.48	6.00	0.00	4.50	0.00	0.00	0.50	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	29.20	8.10	0.75	0.94	0.38	0.57	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	34.56	6.82	0.00	0.91	0.91	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.50	4.39	1.25	0.63	1.88	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	32.99	6.37	2.12	1.14	1.31	0.49	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	28.74	7.84	2.90	1.16	0.58	1.45	0.58	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	25.11	4.48	2.99	0.90	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	12.01	3.14	1.48	0.37	0.18	0.00	0.92	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	12.27	3.71	0.86	0.57	0.00	0.57	0.57	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	19.60	2.86	0.41	2.86	1.22	0.41	0.41	1.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	17.25	3.87	0.35	0.70	0.00	0.00	0.00	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	14.89	2.53	0.95	0.32	0.00	0.32	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.37	6.05	2.72	0.91	0.61	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	6.21	2.07	0.52	2.07	0.52	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	24.57	7.31	2.66	1.33	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.83	5.90	2.82	0.26	1.03	0.00	0.26	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	27.61	7.16	4.86	0.26	1.28	0.51	0.26	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	32.56	9.09	1.51	0.76	0.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	31.25	9.75	2.69	2.02	0.67	1.01	0.34	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.66	2.66	0.24	0.48	0.48	1.45	0.00	0.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	12.48	1.78	0.89	0.45	0.00	0.00	1.34	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.20	4.88	1.46	0.49	0.00	0.00	0.00	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.70	2.44	0.31	0.31	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	217.97	13.01	6.51	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	39.38	3.64	0.66	1.65	0.00	0.33	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	38.86	6.57	2.19	1.64	2.19	0.00	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.61	8.69	1.09	0.36	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	21.71	6.76	1.78	0.71	1.42	0.36	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	28.64	4.77	3.58	0.00	0.00	0.00	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	62.02	11.92	5.01	2.98	1.22	1.22	0.81	0.41	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.94	10.24	2.96	1.08	0.81	0.27	0.00	0.00	0.00
immature langerhans cells, donor1	11904-125F5	3.15	3.15	0.73	0.48	0.97	0.00	5.09	0.00	0.00
immature langerhans cells, donor2	11905-125F6	2.38	4.75	0.00	0.00	0.00	0.00	7.13	0.00	0.00
insula, adult, pool1	10039-101F3	97.95	18.45	6.15	15.43	3.31	10.98	2.93	5.87	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	3.58	3.90	2.28	0.00	0.00	0.00	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	40.95	11.01	6.81	3.30	2.50	0.70	0.70	0.20	0.20
kidney, fetal, pool1	10045-101F9	24.26	10.19	5.52	1.70	2.62	1.06	1.13	0.42	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	293.98	58.37	21.45	21.16	12.36	10.51	13.92	5.25	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.62	6.08	2.63	1.11	1.24	0.00	0.14	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.83	4.95	0.73	1.47	0.73	0.37	0.55	0.00	0.00
left atrium, adult, donor1	10079-102A7	147.11	19.61	7.63	14.71	2.18	4.36	2.18	7.63	4.90
left ventricle, adult, donor1	10078-102A6	164.34	14.66	5.56	23.77	4.05	9.10	0.51	4.55	1.01
leiomyoblastoma cell line:G-402	10721-110A1	39.95	10.40	3.83	1.92	0.27	0.00	1.37	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	92.33	28.02	10.78	7.90	4.31	3.59	1.80	2.16	1.44
leiomyoma cell line:15242A	10570-108B3	91.85	17.93	8.15	2.72	3.26	1.09	1.09	2.17	1.09
leiomyoma cell line:15425	10571-108B4	149.09	29.38	8.50	7.28	3.64	2.91	1.70	1.21	1.21
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	25.40	6.35	6.35	0.00	6.35	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	40.78	9.41	1.05	1.05	1.05	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	4.01	2.36	1.65	0.35	0.47	0.12	0.12	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	47.33	7.50	2.50	4.22	0.78	1.25	0.16	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	46.18	14.13	10.97	3.41	1.95	1.95	2.92	0.73	0.00
liver, adult, pool1	10018-101C9	123.00	44.89	20.26	8.91	6.16	1.46	6.32	0.65	0.16
liver, fetal, pool1	10086-102B5	33.87	7.53	8.47	0.94	0.94	0.00	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	160.70	29.31	10.21	23.04	5.69	15.46	1.46	7.58	0.00
locus coeruleus, adult, donor10252	10165-103B3	109.99	19.01	8.86	20.30	3.32	18.46	1.11	8.12	0.55
locus coeruleus, adult, donor10258	10375-105G6	64.61	14.39	4.51	11.29	1.97	6.49	1.97	4.23	0.00
locus coeruleus, newborn, donor10223	10362-105F2	79.08	14.30	5.05	5.05	0.84	0.84	0.42	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	42.49	15.22	9.13	2.77	2.63	0.42	0.55	0.28	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	5.52	2.76	2.07	0.69	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	13.84	4.22	3.56	0.00	1.71	0.40	1.71	0.13	0.00
lung, adult, pool1	10019-101D1	49.97	9.33	5.67	3.78	2.36	0.59	4.96	0.24	0.83
lung, fetal, donor1	10068-101I5	97.89	19.12	4.85	8.85	3.42	1.71	11.70	1.14	0.57
lung, right lower lobe, adult, donor1	10075-102A3	23.37	6.87	2.75	1.83	0.92	0.00	0.92	0.00	0.00
lymph node, adult, donor1	10077-102A5	8.99	4.26	1.89	1.89	1.89	0.00	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	9.21	3.73	3.73	0.44	0.66	0.00	2.85	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.94	2.41	1.06	0.45	0.15	0.30	0.15	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	16.14	9.34	2.55	1.70	0.85	0.85	4.25	0.00	0.85
mature adipocyte, donor1	12231-129F8	39.96	17.76	12.88	2.66	5.77	0.00	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	75.13	23.66	10.79	6.02	6.23	0.62	1.45	0.42	0.21
mature adipocyte, donor3	12233-129G1	59.74	24.18	11.14	3.32	8.30	0.00	0.95	0.24	0.00
mature adipocyte, donor4	12234-129G2	107.13	31.32	13.42	6.84	6.05	1.05	2.11	0.79	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	3.81	1.43	1.43	0.71	0.00	0.24	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	77.83	10.15	5.64	5.64	3.38	11.28	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	94.71	17.10	5.70	21.15	2.39	15.82	0.74	8.28	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	74.02	12.07	3.18	11.44	1.27	6.35	0.95	6.35	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	44.35	13.65	3.84	4.26	1.71	1.28	0.43	1.28	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	104.12	16.20	6.08	17.04	3.38	15.69	1.35	5.23	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	104.20	14.01	7.43	23.13	3.40	23.98	1.06	7.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	78.98	3.85	1.93	13.48	0.00	11.56	1.93	15.41	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	775.10	100.48	28.71	43.06	0.00	43.06	0.00	28.71	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	16.87	7.18	1.79	1.08	1.08	0.72	1.44	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	83.72	12.33	1.30	15.58	3.24	13.63	0.65	5.19	0.00
medulla oblongata, adult, donor10252	10155-103A2	98.46	19.66	12.38	16.41	4.18	12.69	0.62	6.19	0.15
medulla oblongata, adult, pool1	10038-101F2	155.58	28.32	12.57	23.02	5.14	13.63	0.90	6.86	0.08
medulla oblongata, newborn, donor10223	10361-105F1	66.31	11.11	4.51	9.37	0.35	4.17	0.00	1.39	0.00
medulloblastoma cell line:D283 Med	10838-111E1	248.42	29.89	3.10	23.69	0.66	16.16	0.89	7.31	0.22
medulloblastoma cell line:ONS-76	10759-110E3	15.28	3.67	1.47	0.73	0.49	0.24	0.12	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	60.09	20.99	4.31	2.87	0.72	1.44	0.57	0.86	0.14
melanoma cell line:G-361	10465-106H6	26.87	4.61	1.36	0.81	0.81	0.27	0.54	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	24.24	7.96	1.09	2.17	1.09	0.00	1.45	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	25.55	10.57	6.17	1.76	0.00	0.88	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	36.81	14.00	1.56	2.85	0.52	2.33	1.04	0.78	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	83.93	28.39	6.90	3.84	3.07	1.38	1.53	0.61	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	55.81	20.36	5.45	2.00	2.91	0.18	2.91	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	84.89	24.43	4.97	0.83	2.07	0.83	3.31	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	123.48	37.93	4.50	9.41	2.53	3.09	0.98	0.56	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	85.31	15.21	5.78	8.09	1.54	0.58	3.66	0.96	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	77.74	14.58	6.94	4.16	2.08	0.69	4.16	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	76.21	22.66	2.57	5.49	1.72	1.72	0.34	1.20	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	67.17	16.91	2.99	3.34	1.27	0.81	0.92	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	52.39	15.92	5.04	2.25	2.79	0.40	1.46	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	75.89	20.12	3.92	4.32	1.49	1.22	0.81	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	69.42	27.60	6.83	2.56	3.70	1.00	1.99	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	56.65	14.49	4.28	3.29	1.32	0.33	0.00	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	58.12	21.31	8.16	2.63	3.18	0.83	2.49	0.42	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	51.66	15.01	5.24	1.05	4.19	0.35	1.05	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	71.87	18.17	3.88	6.12	3.06	2.65	2.25	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	64.70	15.10	4.67	1.08	2.52	0.36	1.08	1.44	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	52.14	12.62	3.10	3.21	2.28	1.24	2.17	0.83	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	49.47	12.31	5.47	2.28	1.37	1.60	2.28	0.68	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	144.33	35.24	7.55	7.13	7.13	1.68	2.10	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	104.61	28.84	7.77	4.93	1.79	1.94	2.39	1.64	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	56.89	16.63	4.55	3.41	2.71	0.61	3.15	0.88	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	101.24	19.51	7.73	5.15	0.74	4.42	3.31	1.47	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	60.09	17.74	6.87	4.01	2.00	1.43	2.00	0.57	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	276.61	74.52	13.05	22.31	1.26	8.84	0.00	6.74	5.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	74.89	24.66	5.48	3.20	0.46	0.46	1.37	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	109.73	24.56	8.70	4.86	1.53	2.81	0.26	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	98.94	30.10	5.76	4.97	1.31	1.57	1.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	87.19	27.73	5.85	3.70	0.92	1.54	0.62	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	108.50	32.48	7.77	6.12	0.94	0.94	0.71	0.24	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	109.32	26.74	5.08	6.43	1.02	1.69	0.34	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	97.85	26.33	4.72	4.32	1.18	0.39	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	82.95	28.27	5.10	2.78	1.85	0.93	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	96.61	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	112.77	28.84	7.21	4.61	0.87	1.15	0.58	1.15	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	100.40	32.80	5.58	3.57	1.34	0.67	0.89	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	94.94	28.12	7.45	5.53	2.16	1.20	0.24	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	107.80	39.60	4.40	1.47	2.20	2.93	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	93.31	27.19	7.38	4.03	0.34	0.67	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	90.06	29.88	8.60	4.50	1.64	1.64	0.82	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	89.35	20.19	3.87	3.44	1.72	0.43	2.15	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	73.83	21.88	2.73	10.94	0.00	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	108.46	15.49	0.00	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	99.06	24.36	5.20	4.22	0.32	0.65	2.27	1.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	23.28	10.18	1.45	0.00	2.91	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	93.82	20.79	5.33	3.20	2.67	1.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	67.87	21.26	3.27	2.45	3.27	1.64	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	64.92	20.60	7.39	1.55	0.39	1.94	0.39	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	75.55	33.58	8.39	0.00	0.00	4.20	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	69.54	22.85	4.97	1.99	0.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	4.77	0.00	4.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	71.75	18.97	1.19	3.56	2.37	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	68.23	19.50	7.31	1.22	1.22	1.22	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	69.67	17.73	7.60	1.90	0.63	0.63	2.53	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	39.32	13.80	3.79	1.38	0.00	0.69	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	12.90	4.30	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	7.98	11.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	6.89	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.67	7.74	3.67	0.81	0.00	0.41	0.41	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	8.74	3.18	0.00	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	24.76	7.07	4.13	1.18	1.18	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.57	9.66	3.43	0.00	0.62	0.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	24.06	6.68	2.67	1.34	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	26.02	5.91	1.18	0.00	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	5.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	36.49	5.51	1.38	1.38	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	35.13	11.38	2.47	2.97	1.48	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	47.10	6.73	4.49	2.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	37.53	12.09	3.82	1.27	0.64	0.00	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	43.52	12.90	2.42	2.01	1.21	0.00	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	41.43	6.54	8.72	4.36	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	29.14	5.07	2.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	50.37	10.32	1.21	0.00	1.21	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	85.86	22.59	4.52	0.00	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	11.53	6.59	3.29	1.65	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	49.21	10.52	4.96	2.18	0.20	0.79	0.60	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	35.05	11.68	3.24	1.95	0.97	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	30.56	14.26	7.13	2.04	0.00	1.02	1.02	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	44.88	11.61	3.87	6.19	0.77	5.42	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.00	19.61	6.14	0.71	4.25	0.47	3.78	0.00	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	36.37	6.49	3.24	2.55	1.62	1.16	0.93	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	111.11	21.37	4.27	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	119.81	22.40	2.88	8.63	1.13	1.85	0.21	0.92	0.31
mesothelioma cell line:Mero-25	10850-111F4	20.20	8.85	1.36	1.59	0.00	0.91	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	42.54	7.33	4.40	2.69	1.96	0.24	2.44	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	32.55	5.76	3.10	0.89	1.55	1.55	0.44	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	47.83	7.62	2.89	4.20	1.31	1.58	0.79	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	62.47	12.09	4.77	7.49	1.53	1.19	0.17	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	16.94	5.31	2.78	1.77	1.77	0.51	0.76	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	42.65	12.63	4.55	1.45	1.66	1.45	0.62	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	121.42	20.04	5.63	8.94	2.32	3.31	1.66	1.66	0.66
mesothelioma cell line:NCI-H226	10846-111E9	70.77	14.12	4.34	5.79	1.63	2.17	0.36	1.09	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	27.84	5.81	2.73	2.56	1.37	0.00	0.00	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	14.25	2.04	1.53	0.76	1.27	0.25	0.25	0.25	0.00
mesothelioma cell line:No36	10857-111G2	41.10	5.22	3.59	2.94	1.30	1.63	0.00	1.30	0.00
mesothelioma cell line:ONE58	10858-111G3	60.42	7.04	2.98	5.15	0.54	3.52	0.27	2.44	0.00
migratory langerhans cells, donor1	11901-125F2	14.78	3.07	0.77	0.77	0.38	0.00	1.15	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	10.62	4.15	1.10	0.49	0.37	0.24	0.49	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	15.97	6.46	1.79	0.90	0.36	0.00	0.72	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	110.68	27.42	13.71	9.79	5.55	6.86	4.57	3.26	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	60.61	15.47	15.05	2.97	2.33	1.27	4.03	0.64	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	7.37	5.99	2.53	0.46	0.69	0.23	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1.33	1.14	0.19	0.00	0.00	0.00	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	3.51	3.14	2.96	0.00	0.37	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	7.51	2.57	1.19	0.79	0.79	0.20	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	42.11	15.73	9.13	2.54	2.54	0.51	3.04	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	39.82	8.04	5.49	3.53	1.18	1.57	0.00	0.59	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.93	6.57	2.45	0.67	2.23	0.11	0.67	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	17.21	5.81	3.09	0.81	1.62	0.07	0.22	0.07	0.29
nasal epithelial cells, donor2	12227-129F4	7.73	6.62	3.31	0.00	0.00	0.00	1.10	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	110.43	8.51	5.75	11.04	1.61	3.91	1.61	2.76	0.00
neuroblastoma cell line:NB-1	10539-107G8	127.41	23.39	9.17	5.61	5.61	2.62	2.06	0.94	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	35.64	6.96	3.80	4.01	1.27	1.90	1.27	1.90	0.00
neuroblastoma cell line:NH-12	10555-107I6	57.77	16.77	5.40	5.22	2.24	1.68	1.12	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.73	10.44	4.03	1.66	1.90	0.71	2.37	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	40.86	9.82	3.17	4.28	0.48	0.32	1.58	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	53.33	13.69	8.45	2.21	1.61	0.60	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	15.89	10.81	8.90	1.27	0.00	0.64	3.81	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	81.71	14.37	7.19	3.99	1.86	1.06	2.13	0.80	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	25.20	3.72	2.71	2.03	1.52	0.51	0.17	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.84	7.20	3.20	2.40	3.20	0.80	0.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	59.95	12.50	4.81	5.77	0.64	1.92	0.64	1.28	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	89.34	22.07	4.20	5.78	0.53	1.31	0.26	0.79	0.26
nucleus accumbens, adult, pool1	10037-101F1	100.39	22.12	5.72	21.75	3.56	15.94	3.28	7.50	0.47
occipital cortex - adult, donor10196	10172-103C1	88.60	14.42	4.12	18.54	0.00	18.54	2.06	12.36	0.00
occipital cortex, adult, donor10252	10163-103B1	93.66	17.44	8.86	23.08	2.95	27.37	1.61	10.47	0.00
occipital cortex, newborn, donor10223	10355-105E4	18.56	7.64	1.82	2.55	0.00	1.09	0.36	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	97.09	24.67	6.04	20.73	2.89	20.73	1.57	8.13	0.00
occipital lobe, fetal, donor1	10073-102A1	47.63	8.58	4.29	4.29	2.15	0.00	2.15	0.43	0.00
occipital pole, adult, pool1	10036-101E9	67.25	20.50	5.68	13.17	4.49	10.56	1.97	5.99	0.00
olfactory region, adult	10195-103E6	68.78	15.86	3.06	15.48	1.72	9.93	1.91	8.41	0.19
optic nerve, donor1	10277-104E7	174.09	24.01	8.00	28.01	8.00	34.02	2.00	20.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	17.77	7.86	3.30	1.14	2.39	0.34	0.57	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	20.61	3.57	1.10	0.69	0.82	0.14	0.69	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.44	6.26	2.54	0.17	0.85	0.34	0.85	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.48	4.97	4.85	0.69	1.73	0.23	1.27	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	94.66	19.40	7.06	4.70	1.76	3.82	1.18	1.18	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	15.88	3.74	2.80	0.00	2.80	0.00	6.54	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	47.93	9.75	3.18	6.79	1.48	2.97	0.00	3.39	0.00
ovary, adult, pool1	10020-101D2	74.34	17.12	10.39	5.33	5.07	0.52	3.67	0.35	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	78.28	17.60	5.32	6.97	0.73	2.02	4.22	0.92	1.47
pancreas, adult, donor1	10049-101G4	7.53	3.76	0.94	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	8.95	12.58	9.50	0.56	3.07	0.00	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	58.43	10.90	3.07	4.26	1.02	1.19	0.17	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	17.39	4.31	1.82	1.49	1.32	0.66	1.99	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	124.47	29.29	8.05	20.50	4.39	13.18	2.65	6.50	0.09
parietal cortex, adult, donor10258	10373-105G4	57.25	14.68	1.47	13.95	0.73	5.87	0.73	7.34	0.00
parietal lobe - adult, donor10196	10171-103B9	98.75	15.99	2.82	15.99	2.82	18.81	0.94	6.58	0.00
parietal lobe, adult, donor10252	10157-103A4	89.22	12.26	5.13	14.82	3.71	13.68	0.86	6.27	0.00
parietal lobe, adult, pool1	10034-101E7	114.91	23.26	7.75	21.59	3.79	15.51	2.47	7.58	0.00
parietal lobe, fetal, donor1	10072-101I9	54.31	16.49	3.88	2.91	4.85	1.94	4.85	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	18.69	4.49	1.50	1.12	1.50	1.87	0.75	0.75	0.00
parotid gland, adult	10199-103F1	19.73	8.02	1.23	0.62	1.23	1.23	0.00	0.62	0.00
penis, adult	10200-103F2	196.05	48.88	13.96	28.47	4.30	19.87	0.00	6.45	4.30
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.13	8.55	5.39	0.74	2.42	0.19	2.60	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.83	10.49	4.52	1.75	1.02	0.29	3.93	0.15	0.87
pineal gland - adult, donor10196	10179-103C8	74.82	9.68	2.58	5.81	2.58	2.58	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	100.68	14.21	5.33	13.03	1.78	7.11	0.00	1.78	0.00
pineal gland, adult, donor10258	10377-105G8	69.61	8.15	5.64	6.27	1.25	1.88	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	40.47	8.09	1.01	7.08	1.01	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	72.97	21.37	7.82	7.82	0.52	2.61	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	31.50	3.40	7.66	5.11	0.00	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	38.81	9.46	3.76	2.80	2.37	1.72	0.65	0.11	0.97
plasma cell leukemia cell line:ARH-77	10840-111E3	6.75	5.30	0.93	0.79	0.26	0.13	0.26	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.75	4.20	2.02	2.33	0.93	1.56	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	217.84	50.52	13.60	27.37	5.77	13.86	3.10	8.26	0.43
postcentral gyrus, adult, pool1	10032-101E5	88.57	21.18	8.19	16.13	4.18	10.90	1.66	5.93	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	4.18	0.00	4.18	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	188.78	56.66	29.42	10.49	16.31	3.50	5.39	1.89	0.29
prostate cancer cell line:PC-3	10439-106E7	113.26	29.40	11.07	6.35	4.17	1.09	1.45	0.54	0.00
prostate, adult, pool1	10022-101D4	137.85	20.22	8.43	14.06	4.63	3.17	1.45	1.09	1.72
putamen, adult, donor10196	10176-103C5	45.09	8.03	5.19	8.97	4.01	8.97	11.09	5.43	0.00
putamen, adult, donor10252	10152-102I8	74.51	25.49	3.92	41.18	1.96	19.61	3.92	13.73	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	44.81	4.37	0.00	5.46	0.00	7.65	0.00	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	46.15	6.52	4.11	6.04	3.38	5.80	7.01	4.59	0.00
putamen, newborn, donor10223	10365-105F5	110.20	12.74	4.50	8.25	0.75	3.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	1.45	2.33	1.45	0.00	0.58	0.29	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	69.55	26.43	11.13	4.17	5.56	5.56	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	81.20	11.02	4.03	5.94	1.91	3.82	0.42	1.48	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	17.81	3.73	2.49	2.07	1.66	0.41	2.49	0.00	0.00
retina, adult, pool1	10030-101E3	72.76	17.10	7.75	6.06	4.37	1.89	0.89	1.09	0.20
retinoblastoma cell line:Y79	10475-106I7	27.54	7.79	2.34	0.52	1.56	0.26	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	53.11	25.33	14.38	2.46	2.58	0.49	2.70	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	123.45	32.90	9.28	6.19	3.66	5.91	5.34	3.94	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	48.50	8.34	9.85	4.55	1.52	1.52	4.55	0.00	0.00
salivary acinar cells, donor1	11771-123I7	8.42	2.43	1.13	0.32	1.29	0.16	0.81	0.00	0.32
salivary acinar cells, donor2	11772-123I8	9.91	1.79	1.24	0.55	0.55	0.28	0.41	0.14	0.14
salivary acinar cells, donor3	11773-123I9	7.94	3.97	1.99	0.00	0.66	0.66	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	26.31	8.58	2.86	2.29	3.43	1.14	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	169.55	40.05	12.39	6.41	7.00	2.53	3.63	1.52	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	135.18	32.80	15.16	6.00	4.23	2.82	2.70	1.18	0.00
seminal vesicle, adult	10201-103F3	67.72	13.76	4.23	5.29	4.76	4.23	0.00	0.53	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	36.20	5.59	2.19	2.67	0.97	1.70	7.29	0.73	2.92
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	38.75	7.30	2.26	3.77	0.50	2.01	2.01	0.75	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	69.24	2.01	3.01	1.00	1.00	1.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.91	5.24	1.75	1.07	1.07	0.54	0.13	0.40	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	8.62	5.08	2.76	0.77	0.33	0.00	0.00	0.11	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	1.68	0.52	0.65	0.00	0.39	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	759.70	126.26	17.02	79.45	16.31	29.79	0.71	14.90	19.15
skeletal muscle, adult, pool1	10023-101D5	567.18	116.46	14.39	87.43	8.52	28.19	0.72	16.91	22.31
skeletal muscle, fetal, donor1	10066-101I3	149.75	47.24	2.01	17.09	1.01	16.08	3.02	6.03	5.03
skin, adult, donor1	10074-102A2	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	94.05	27.14	11.99	10.10	2.52	6.31	1.26	4.42	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	24.68	7.67	2.00	2.33	0.33	1.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	87.94	15.76	4.73	8.51	1.26	6.62	0.63	5.36	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	125.09	45.49	5.78	11.76	2.89	6.36	10.79	6.17	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	22.91	6.43	1.81	1.32	1.81	0.33	0.00	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	32.49	5.63	0.48	1.13	0.00	0.16	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	33.56	14.16	10.24	2.83	2.62	1.74	1.09	0.44	0.22
small intestine, adult, pool1	10024-101D6	53.15	8.00	3.82	5.14	1.19	1.07	0.84	0.36	0.48
small intestine, fetal, donor1	10064-101I1	25.80	6.14	3.44	3.69	1.47	0.74	0.00	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	8.21	1.03	0.00	0.00	0.51	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	241.14	40.06	16.28	24.81	7.24	10.08	0.52	2.58	6.72
somatostatinoma cell line:QGP-1	10781-110G7	1.88	1.07	0.80	0.00	0.54	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	161.96	18.58	11.24	27.76	4.59	15.83	0.92	7.11	0.69
spinal cord, adult, donor10252	10159-103A6	128.93	23.26	11.43	18.92	5.52	12.22	0.39	6.31	0.39
spinal cord, adult, donor10258	10369-105F9	108.61	14.53	3.46	17.29	4.84	12.45	0.69	13.14	0.00
spinal cord, fetal, donor1	10056-101H2	64.64	17.08	18.30	7.32	3.05	7.93	3.05	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	168.99	27.09	10.10	19.75	1.38	15.61	0.00	5.97	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	116.80	31.22	10.01	5.53	1.94	1.94	1.64	2.09	0.60
spleen, adult, pool1	10025-101D7	21.70	6.61	3.63	1.54	1.43	0.11	0.22	0.11	0.11
spleen, fetal, pool1	10044-101F8	14.06	5.09	2.15	1.03	1.35	0.40	0.64	0.00	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.07	4.04	0.93	0.31	0.52	0.10	0.21	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	22.79	5.89	4.37	1.52	2.09	0.57	5.70	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.55	17.82	13.63	5.94	3.49	2.45	1.40	1.05	2.45
squamous cell carcinoma cell line:T3M-5	10616-108G4	16.03	4.69	2.35	1.56	0.39	0.00	0.00	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	35.46	11.37	8.22	2.81	3.49	0.56	2.25	0.23	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	11.01	5.51	4.24	1.27	2.12	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	46.11	18.19	5.08	2.12	2.96	3.81	0.42	0.85	0.00
stomach, fetal, donor1	10062-101H8	103.59	17.09	6.41	12.82	0.00	5.34	3.20	3.20	0.00
submaxillary gland, adult	10202-103F4	29.62	5.70	3.99	2.85	0.57	1.71	0.57	2.28	0.00
substantia nigra - adult, donor10196	10178-103C7	434.19	108.55	0.00	162.82	0.00	162.82	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	141.03	23.26	11.22	38.22	3.53	36.97	0.42	20.98	0.42
substantia nigra, adult, donor10258	10371-105G2	90.52	14.48	3.10	13.45	1.55	17.59	0.52	5.17	0.00
substantia nigra, newborn, donor10223	10358-105E7	94.68	21.90	1.41	7.77	2.83	9.19	1.41	4.24	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	12.38	9.17	3.44	0.69	0.69	0.23	0.00	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	62.90	19.75	5.26	10.77	2.03	8.31	1.10	5.09	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	27.07	7.12	4.99	0.71	1.42	2.85	2.85	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	24.61	7.91	4.40	1.32	2.20	2.20	2.64	0.44	0.00
tenocyte, donor1	11763-123H8	84.48	24.09	6.63	4.54	2.79	0.35	1.75	0.70	0.00
tenocyte, donor2	11765-123I1	58.75	17.55	6.49	3.05	1.53	1.14	0.38	0.38	0.38
tenocyte, donor3	11768-123I4	136.03	20.76	7.04	8.15	3.34	2.97	2.22	2.59	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	21.25	10.37	2.04	0.51	0.85	0.00	0.17	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	53.64	13.26	7.71	2.93	1.54	1.54	0.31	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	17.82	4.65	1.39	0.77	0.62	0.62	0.00	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	15.11	6.73	2.03	0.89	0.25	0.25	0.13	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	7.56	3.03	0.76	0.38	1.51	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	7.31	3.71	1.20	0.44	0.98	0.00	0.44	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	1.63	3.26	0.33	0.00	0.33	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	86.86	19.76	7.84	6.12	4.40	1.18	3.76	1.18	0.54
testis, adult, pool2	10096-102C6	48.27	14.43	7.22	2.71	4.06	0.90	4.51	0.90	0.00
thalamus - adult, donor10196	10168-103B6	165.60	14.35	6.62	55.20	2.21	35.33	0.00	12.14	0.00
thalamus, adult, donor10252	10154-103A1	152.53	23.29	7.81	43.60	3.44	45.01	0.94	17.50	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	197.07	13.86	7.70	38.49	1.54	47.73	1.54	16.94	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	65.71	11.53	4.78	12.02	2.64	8.23	0.66	3.62	0.00
thalamus, newborn, donor10223	10366-105F6	35.67	8.05	2.88	5.18	1.15	0.58	0.58	0.58	0.00
throat, adult	10209-103G2	193.49	32.46	8.74	31.46	2.75	19.47	0.50	10.74	6.99
throat, fetal, donor1	10061-101H7	94.76	20.11	6.40	14.63	3.35	9.14	1.83	3.96	4.57
thymic carcinoma cell line:Ty-82	10803-111A2	26.83	9.54	3.78	0.99	1.79	0.00	1.39	0.40	0.00
thymus, adult, pool1	10027-101D9	6.66	3.88	1.69	0.10	1.19	0.00	1.29	0.00	0.10
thymus, fetal, pool1	10043-101F7	15.69	6.34	2.91	1.25	1.35	0.21	1.77	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	70.47	14.09	3.59	6.78	1.06	2.66	0.53	0.80	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	78.51	17.18	10.62	5.59	1.54	2.10	0.98	0.42	0.14
thyroid, adult, pool1	10028-101E1	59.16	13.06	7.09	4.85	2.89	1.49	1.31	0.56	0.37
thyroid, fetal, donor1	10060-101H6	44.30	7.38	3.43	5.01	2.90	4.22	0.53	1.58	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	98.55	24.64	0.00	9.24	3.08	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	195.60	28.61	3.72	31.17	3.26	14.65	0.00	9.77	3.02
tongue, fetal, donor1	10059-101H5	344.83	84.34	10.25	50.44	1.58	27.19	0.00	15.37	8.67
tonsil, adult, pool1	10047-101G2	30.55	8.11	4.21	3.31	1.80	1.00	0.80	0.30	1.60
trachea, adult, pool1	10029-101E2	39.51	8.10	3.19	3.68	1.80	0.82	1.64	0.49	0.82
trachea, fetal, donor1	10058-101H4	44.24	13.08	5.00	8.08	2.31	3.85	2.31	2.31	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	71.56	13.82	10.98	1.42	2.13	1.06	1.06	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	28.37	5.78	2.43	1.52	0.91	0.71	1.72	0.10	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	87.90	19.90	9.40	4.70	3.29	1.57	4.39	1.10	2.35
tridermal teratoma cell line:HGRT	10694-109G1	85.61	24.73	9.51	5.71	0.00	7.61	0.00	5.71	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	17.27	3.56	2.37	1.52	1.27	0.17	0.17	0.34	0.00
umbilical cord, fetal, donor1	10057-101H3	127.28	29.21	8.35	8.35	2.09	4.17	4.17	2.09	4.17
uterus, adult, pool1	10100-102D1	180.70	32.42	7.00	13.99	5.80	3.24	3.41	1.37	0.34
uterus, fetal, donor1	10055-101H1	63.99	14.33	7.17	4.10	4.10	1.54	1.02	0.00	0.00
vagina, adult	10204-103F6	59.45	18.74	5.82	4.52	1.29	4.52	0.00	0.65	0.00
vein, adult	10191-103E2	35.73	11.40	3.95	3.29	1.10	0.88	0.66	0.66	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.68	2.67	0.80	0.00	0.27	0.00	0.53	0.00	0.00